JP2007143562A5 - - Google Patents

Info

Publication number

JP2007143562A5

JP2007143562A5 JP2007059288A JP2007059288A JP2007143562A5 JP 2007143562 A5 JP2007143562 A5 JP 2007143562A5 JP 2007059288 A JP2007059288 A JP 2007059288A JP 2007059288 A JP2007059288 A JP 2007059288A JP 2007143562 A5 JP2007143562 A5 JP 2007143562A5

Authority

JP

Japan

Prior art keywords

cell

organism

gene

dna polymerase

present

Prior art date

2007-03-08

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 210000004027 cells Anatomy 0.000 description 385
• 230000035772 mutation Effects 0.000 description 199
• 150000007523 nucleic acids Chemical class 0.000 description 186
• 101700011961 DPOM Proteins 0.000 description 140
• 101710029649 MDV043 Proteins 0.000 description 140
• 101700061424 POLB Proteins 0.000 description 140
• 101700054624 RF1 Proteins 0.000 description 140
• 108020004707 nucleic acids Proteins 0.000 description 125
• 235000001014 amino acid Nutrition 0.000 description 110
• 230000002068 genetic Effects 0.000 description 106
• 241000699666 Mus <mouse, genus> Species 0.000 description 103
• 230000014509 gene expression Effects 0.000 description 102
• 150000001413 amino acids Chemical class 0.000 description 100
• 230000001915 proofreading Effects 0.000 description 100
• 241000196324 Embryophyta Species 0.000 description 97
• 229920001184 polypeptide Polymers 0.000 description 96
• 238000000034 method Methods 0.000 description 95
• 229920003013 deoxyribonucleic acid Polymers 0.000 description 88
• 201000010099 disease Diseases 0.000 description 84
• 125000003729 nucleotide group Chemical class 0.000 description 81
• 229920001850 Nucleic acid sequence Polymers 0.000 description 77
• 239000002773 nucleotide Substances 0.000 description 77
• 230000000694 effects Effects 0.000 description 70
• 239000002585 base Substances 0.000 description 66
• 239000002609 media Substances 0.000 description 66
• 238000006243 chemical reaction Methods 0.000 description 63
• 229920000023 polynucleotide Polymers 0.000 description 63
• 239000002157 polynucleotide Substances 0.000 description 63
• 239000000126 substance Substances 0.000 description 62
• 210000001519 tissues Anatomy 0.000 description 60
• 239000003814 drug Substances 0.000 description 57
• 102000004169 proteins and genes Human genes 0.000 description 57
• 108090000623 proteins and genes Proteins 0.000 description 57
• 235000018102 proteins Nutrition 0.000 description 55
• 108010071146 DNA Polymerase III Proteins 0.000 description 52
• 102000007528 DNA Polymerase III Human genes 0.000 description 52
• FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 51
• 238000004519 manufacturing process Methods 0.000 description 47
• 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 46
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 46
• 239000011780 sodium chloride Substances 0.000 description 46
• 235000002639 sodium chloride Nutrition 0.000 description 46
• 239000000203 mixture Substances 0.000 description 42
• 239000000047 product Substances 0.000 description 41
• 238000003752 polymerase chain reaction Methods 0.000 description 40
• 229940079593 drugs Drugs 0.000 description 39
• 108010063113 DNA Polymerase II Proteins 0.000 description 38
• 102000010567 DNA Polymerase II Human genes 0.000 description 38
• 101710040092 POLD1 Proteins 0.000 description 38
• 230000012010 growth Effects 0.000 description 37
• 241000206602 Eukaryota Species 0.000 description 36
• 210000000130 stem cell Anatomy 0.000 description 34
• 230000000875 corresponding Effects 0.000 description 33
• 230000004048 modification Effects 0.000 description 33
• 238000006011 modification reaction Methods 0.000 description 33
• 238000002360 preparation method Methods 0.000 description 32
• 230000001105 regulatory Effects 0.000 description 32
• 125000003275 alpha amino acid group Chemical group 0.000 description 30
• 230000036961 partial Effects 0.000 description 30
• 230000001131 transforming Effects 0.000 description 30
• 108010051219 Cre recombinase Proteins 0.000 description 29
• 206010020649 Hyperkeratosis Diseases 0.000 description 29
• 238000006467 substitution reaction Methods 0.000 description 29
• 210000000056 organs Anatomy 0.000 description 28
• 102000004190 Enzymes Human genes 0.000 description 27
• 108090000790 Enzymes Proteins 0.000 description 27
• 229920000272 Oligonucleotide Polymers 0.000 description 27
• 238000009396 hybridization Methods 0.000 description 26
• 230000000051 modifying Effects 0.000 description 26
• 241000699660 Mus musculus Species 0.000 description 25
• 108090001123 antibodies Proteins 0.000 description 25
• 102000004965 antibodies Human genes 0.000 description 25
• 241000588724 Escherichia coli Species 0.000 description 23
• 241000282414 Homo sapiens Species 0.000 description 23
• 229920002676 Complementary DNA Polymers 0.000 description 22
• 238000005516 engineering process Methods 0.000 description 22
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
• 238000005215 recombination Methods 0.000 description 22
• 230000000295 complement Effects 0.000 description 21
• 150000001875 compounds Chemical class 0.000 description 21
• 230000001965 increased Effects 0.000 description 21
• 230000033458 reproduction Effects 0.000 description 21
• 241000894006 Bacteria Species 0.000 description 20
• 102000016928 DNA-Directed DNA Polymerase Human genes 0.000 description 20
• 108010014303 DNA-Directed DNA Polymerase Proteins 0.000 description 20
• 229940088598 Enzyme Drugs 0.000 description 20
• 241001465754 Metazoa Species 0.000 description 20
• 239000003795 chemical substances by application Substances 0.000 description 20
• 239000002207 metabolite Substances 0.000 description 20
• 150000003839 salts Chemical class 0.000 description 20
• 241000894007 species Species 0.000 description 20
• 101710025012 FTHL17 Proteins 0.000 description 19
• 210000003527 eukaryotic cell Anatomy 0.000 description 19
• 231100000350 mutagenesis Toxicity 0.000 description 19
• 239000000243 solution Substances 0.000 description 19
• 238000011144 upstream manufacturing Methods 0.000 description 19
• 108020004999 Messenger RNA Proteins 0.000 description 18
• 229920002106 messenger RNA Polymers 0.000 description 18
• 238000002703 mutagenesis Methods 0.000 description 18
• 230000021595 spermatogenesis Effects 0.000 description 18
• 239000002299 complementary DNA Substances 0.000 description 17
• 238000007796 conventional method Methods 0.000 description 17
• 230000004543 DNA replication Effects 0.000 description 16
• 230000033228 biological regulation Effects 0.000 description 16
• ZHNUHDYFZUAESO-UHFFFAOYSA-N formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 16
• 238000003786 synthesis reaction Methods 0.000 description 16
• 108009000097 DNA Replication Proteins 0.000 description 15
• 230000027455 binding Effects 0.000 description 15
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 15
• 238000004458 analytical method Methods 0.000 description 14
• 238000002474 experimental method Methods 0.000 description 14
• 239000007788 liquid Substances 0.000 description 14
• 230000035882 stress Effects 0.000 description 14
• 101700008821 EXO Proteins 0.000 description 13
• 101700083023 EXRN Proteins 0.000 description 13
• 241000700159 Rattus Species 0.000 description 13
• 210000001550 Testis Anatomy 0.000 description 13
• 230000015572 biosynthetic process Effects 0.000 description 13
• 201000011510 cancer Diseases 0.000 description 13
• 238000010367 cloning Methods 0.000 description 13
• 239000007787 solid Substances 0.000 description 13
• 230000002194 synthesizing Effects 0.000 description 13
• 241000192125 Firmicutes Species 0.000 description 12
• 240000007594 Oryza sativa Species 0.000 description 12
• 235000007164 Oryza sativa Nutrition 0.000 description 12
• 230000025458 RNA interference Effects 0.000 description 12
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 12
• UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 12
• 108091006028 chimera Proteins 0.000 description 12
• 230000005484 gravity Effects 0.000 description 12
• 239000007924 injection Substances 0.000 description 12
• 239000000463 material Substances 0.000 description 12
• 239000003960 organic solvent Substances 0.000 description 12
• 235000009566 rice Nutrition 0.000 description 12
• 235000019333 sodium laurylsulphate Nutrition 0.000 description 12
• 230000035897 transcription Effects 0.000 description 12
• 240000008371 Bacillus subtilis Species 0.000 description 11
• 229940075615 Bacillus subtilis Drugs 0.000 description 11
• 235000014469 Bacillus subtilis Nutrition 0.000 description 11
• 210000000349 Chromosomes Anatomy 0.000 description 11
• 206010059866 Drug resistance Diseases 0.000 description 11
• 238000010363 gene targeting Methods 0.000 description 11
• 238000002347 injection Methods 0.000 description 11
• 239000003471 mutagenic agent Substances 0.000 description 11
• 230000002829 reduced Effects 0.000 description 11
• 229940064005 Antibiotic throat preparations Drugs 0.000 description 10
• 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 description 10
• 229940042052 Antibiotics for systemic use Drugs 0.000 description 10
• 229940042786 Antitubercular Antibiotics Drugs 0.000 description 10
• 229940093922 Gynecological Antibiotics Drugs 0.000 description 10
• 241000283984 Rodentia Species 0.000 description 10
• 210000002921 Spermatogonia Anatomy 0.000 description 10
• 229940024982 Topical Antifungal Antibiotics Drugs 0.000 description 10
• 239000003242 anti bacterial agent Substances 0.000 description 10
• 230000003115 biocidal Effects 0.000 description 10
• 238000004520 electroporation Methods 0.000 description 10
• 239000007789 gas Substances 0.000 description 10
• 238000002744 homologous recombination Methods 0.000 description 10
• 229940079866 intestinal antibiotics Drugs 0.000 description 10
• 229910052751 metal Inorganic materials 0.000 description 10
• 239000002184 metal Substances 0.000 description 10
• 229940005935 ophthalmologic Antibiotics Drugs 0.000 description 10
• 229920000160 (ribonucleotides)n+m Polymers 0.000 description 9
• 241000589158 Agrobacterium Species 0.000 description 9
• 241000283690 Bos taurus Species 0.000 description 9
• CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 9
• 238000002105 Southern blotting Methods 0.000 description 9
• 229920002472 Starch Polymers 0.000 description 9
• 229940032147 Starch Drugs 0.000 description 9
• 230000002159 abnormal effect Effects 0.000 description 9
• DHMQDGOQFOQNFH-UHFFFAOYSA-N glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 9
• 229960004927 neomycin Drugs 0.000 description 9
• 229920000642 polymer Polymers 0.000 description 9
• 239000001509 sodium citrate Substances 0.000 description 9
• 239000008107 starch Substances 0.000 description 9
• 235000019698 starch Nutrition 0.000 description 9
• 230000001629 suppression Effects 0.000 description 9
• 239000011778 trisodium citrate Substances 0.000 description 9
• 229960005261 Aspartic Acid Drugs 0.000 description 8
• 210000002459 Blastocyst Anatomy 0.000 description 8
• 229940098773 Bovine Serum Albumin Drugs 0.000 description 8
• 108091003117 Bovine Serum Albumin Proteins 0.000 description 8
• WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
• 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 8
• 229960002989 Glutamic Acid Drugs 0.000 description 8
• 241000238631 Hexapoda Species 0.000 description 8
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 8
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 8
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 8
• 241000124008 Mammalia Species 0.000 description 8
• 210000003915 Spermatocytes Anatomy 0.000 description 8
• CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 8
• 229960004793 Sucrose Drugs 0.000 description 8
• HRXKRNGNAMMEHJ-UHFFFAOYSA-K Trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 8
• 235000004279 alanine Nutrition 0.000 description 8
• 235000003704 aspartic acid Nutrition 0.000 description 8
• 239000003124 biologic agent Substances 0.000 description 8
• VTYYLEPIZMXCLO-UHFFFAOYSA-L calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 8
• 230000018109 developmental process Effects 0.000 description 8
• 238000009826 distribution Methods 0.000 description 8
• 235000013601 eggs Nutrition 0.000 description 8
• 210000002257 embryonic structures Anatomy 0.000 description 8
• 239000003623 enhancer Substances 0.000 description 8
• 230000002708 enhancing Effects 0.000 description 8
• 239000008103 glucose Substances 0.000 description 8
• 235000013922 glutamic acid Nutrition 0.000 description 8
• 239000004220 glutamic acid Substances 0.000 description 8
• 239000003446 ligand Substances 0.000 description 8
• 230000003340 mental Effects 0.000 description 8
• 238000010369 molecular cloning Methods 0.000 description 8
• 239000005445 natural product Substances 0.000 description 8
• 229930014626 natural products Natural products 0.000 description 8
• 235000016709 nutrition Nutrition 0.000 description 8
• 230000035764 nutrition Effects 0.000 description 8
• 210000001236 prokaryotic cell Anatomy 0.000 description 8
• 238000001711 protein immunostaining Methods 0.000 description 8
• 230000001172 regenerating Effects 0.000 description 8
• 229960002668 sodium chloride Drugs 0.000 description 8
• 239000005720 sucrose Substances 0.000 description 8
• 238000001262 western blot Methods 0.000 description 8
• WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 8
• 241000219194 Arabidopsis Species 0.000 description 7
• 241000219195 Arabidopsis thaliana Species 0.000 description 7
• 108020004705 Codon Proteins 0.000 description 7
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 7
• 229940110715 ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS Drugs 0.000 description 7
• 108010010803 Gelatin Proteins 0.000 description 7
• 229940014259 Gelatin Drugs 0.000 description 7
• 235000010469 Glycine max Nutrition 0.000 description 7
• 240000007842 Glycine max Species 0.000 description 7
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 7
• 230000036740 Metabolism Effects 0.000 description 7
• 108091005503 Nucleic proteins Proteins 0.000 description 7
• 101710040024 POLE Proteins 0.000 description 7
• 108010010677 Phosphodiesterase I Proteins 0.000 description 7
• 238000007792 addition Methods 0.000 description 7
• 230000003321 amplification Effects 0.000 description 7
• 210000004102 animal cell Anatomy 0.000 description 7
• 230000000692 anti-sense Effects 0.000 description 7
• 238000004166 bioassay Methods 0.000 description 7
• 230000001488 breeding Effects 0.000 description 7
• -1 ethanol Alcohols Chemical class 0.000 description 7
• 239000008273 gelatin Substances 0.000 description 7
• 229920000159 gelatin Polymers 0.000 description 7
• 235000019322 gelatine Nutrition 0.000 description 7
• 235000011852 gelatine desserts Nutrition 0.000 description 7
• 238000010353 genetic engineering Methods 0.000 description 7
• 229940020899 hematological Enzymes Drugs 0.000 description 7
• 238000000338 in vitro Methods 0.000 description 7
• 230000000977 initiatory Effects 0.000 description 7
• 230000004060 metabolic process Effects 0.000 description 7
• 230000035786 metabolism Effects 0.000 description 7
• 238000003199 nucleic acid amplification method Methods 0.000 description 7
• 150000003384 small molecules Chemical class 0.000 description 7
• 239000011734 sodium Substances 0.000 description 7
• 239000002904 solvent Substances 0.000 description 7
• 239000003826 tablet Substances 0.000 description 7
• 239000004475 Arginine Substances 0.000 description 6
• 108010017826 DNA Polymerase I Proteins 0.000 description 6
• 102000004594 DNA Polymerase I Human genes 0.000 description 6
• 210000001161 Embryo, Mammalian Anatomy 0.000 description 6
• 239000002202 Polyethylene glycol Substances 0.000 description 6
• PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 6
• 229920002684 Sepharose Polymers 0.000 description 6
• 241000209149 Zea Species 0.000 description 6
• 235000002017 Zea mays subsp mays Nutrition 0.000 description 6
• 238000001042 affinity chromatography Methods 0.000 description 6
• 239000000427 antigen Substances 0.000 description 6
• 108091007172 antigens Proteins 0.000 description 6
• 102000038129 antigens Human genes 0.000 description 6
• 229960003121 arginine Drugs 0.000 description 6
• 235000009697 arginine Nutrition 0.000 description 6
• WVDDGKGOMKODPV-UHFFFAOYSA-N benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 6
• 238000004587 chromatography analysis Methods 0.000 description 6
• 235000005822 corn Nutrition 0.000 description 6
• 235000005824 corn Nutrition 0.000 description 6
• 238000011161 development Methods 0.000 description 6
• 238000010586 diagram Methods 0.000 description 6
• 235000019688 fish Nutrition 0.000 description 6
• 244000005700 microbiome Species 0.000 description 6
• IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
• 229920001223 polyethylene glycol Polymers 0.000 description 6
• 239000000843 powder Substances 0.000 description 6
• 108060006962 recR Proteins 0.000 description 6
• 210000001082 somatic cell Anatomy 0.000 description 6
• 238000005406 washing Methods 0.000 description 6
• 241000251468 Actinopterygii Species 0.000 description 5
• 229960001230 Asparagine Drugs 0.000 description 5
• 210000004556 Brain Anatomy 0.000 description 5
• YPHMISFOHDHNIV-FSZOTQKASA-N Cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 description 5
• 229960002433 Cysteine Drugs 0.000 description 5
• OPTASPLRGRRNAP-UHFFFAOYSA-N Cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 5
• FBPFZTCFMRRESA-KAZBKCHUSA-N D-Mannitol Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KAZBKCHUSA-N 0.000 description 5
• 108010001132 DNA Polymerase beta Proteins 0.000 description 5
• 102000001996 DNA Polymerase beta Human genes 0.000 description 5
• 210000000918 Epididymis Anatomy 0.000 description 5
• 241000233866 Fungi Species 0.000 description 5
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 5
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 5
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 5
• 239000004472 Lysine Substances 0.000 description 5
• FBPFZTCFMRRESA-KVTDHHQDSA-N Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 5
• 238000000636 Northern blotting Methods 0.000 description 5
• 206010035226 Plasma cell myeloma Diseases 0.000 description 5
• 241000288906 Primates Species 0.000 description 5
• 210000003491 Skin Anatomy 0.000 description 5
• 240000008529 Triticum aestivum Species 0.000 description 5
• ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 5
• 239000002253 acid Substances 0.000 description 5
• 235000009582 asparagine Nutrition 0.000 description 5
• 239000000969 carrier Substances 0.000 description 5
• 238000005094 computer simulation Methods 0.000 description 5
• 230000023298 conjugation with cellular fusion Effects 0.000 description 5
• 230000001276 controlling effect Effects 0.000 description 5
• 235000018417 cysteine Nutrition 0.000 description 5
• 230000004069 differentiation Effects 0.000 description 5
• 239000003937 drug carrier Substances 0.000 description 5
• KCXVZYZYPLLWCC-UHFFFAOYSA-N edta Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
• 210000004602 germ cell Anatomy 0.000 description 5
• 235000004554 glutamine Nutrition 0.000 description 5
• PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
• 239000001963 growth media Substances 0.000 description 5
• 235000010355 mannitol Nutrition 0.000 description 5
• 230000013011 mating Effects 0.000 description 5
• 239000011159 matrix material Substances 0.000 description 5
• 239000012528 membrane Substances 0.000 description 5
• 230000003505 mutagenic Effects 0.000 description 5
• 231100000707 mutagenic chemical Toxicity 0.000 description 5
• 230000002018 overexpression Effects 0.000 description 5
• 230000001575 pathological Effects 0.000 description 5
• 239000008194 pharmaceutical composition Substances 0.000 description 5
• 101700021625 pol2 Proteins 0.000 description 5
• 102000004196 processed proteins & peptides Human genes 0.000 description 5
• 108090000765 processed proteins & peptides Proteins 0.000 description 5
• 108020003175 receptors Proteins 0.000 description 5
• 102000005962 receptors Human genes 0.000 description 5
• 239000011347 resin Substances 0.000 description 5
• 229920005989 resin Polymers 0.000 description 5
• 108091007521 restriction endonucleases Proteins 0.000 description 5
• 238000002741 site-directed mutagenesis Methods 0.000 description 5
• 239000000758 substrate Substances 0.000 description 5
• 230000021037 unidirectional conjugation Effects 0.000 description 5
• 239000004474 valine Substances 0.000 description 5
• 235000021307 wheat Nutrition 0.000 description 5
• UCSJYZPVAKXKNQ-HZYVHMACSA-N 1-[(1S,2R,3R,4S,5R,6R)-3-carbamimidamido-6-{[(2R,3R,4R,5S)-3-{[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy}-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy}-2,4,5-trihydroxycyclohexyl]guanidine Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
• 241000269328 Amphibia Species 0.000 description 4
• 241000271566 Aves Species 0.000 description 4
• 229960003563 Calcium Carbonate Drugs 0.000 description 4
• MTCFGRXMJLQNBG-UWTATZPHSA-N D-serine Chemical compound OC[C@@H](N)C(O)=O MTCFGRXMJLQNBG-UWTATZPHSA-N 0.000 description 4
• QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 description 4
• 231100000277 DNA damage Toxicity 0.000 description 4
• 210000001671 Embryonic Stem Cells Anatomy 0.000 description 4
• 239000004471 Glycine Substances 0.000 description 4
• 241000282412 Homo Species 0.000 description 4
• 229960000310 ISOLEUCINE Drugs 0.000 description 4
• SBUJHOSQTJFQJX-NOAMYHISSA-N Kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 4
• XUJNEKJLAYXESH-REOHCLBHSA-N L-cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 4
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 4
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 4
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 4
• GUBGYTABKSRVRQ-UUNJERMWSA-N Lactose Natural products O([C@@H]1[C@H](O)[C@H](O)[C@H](O)O[C@@H]1CO)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 GUBGYTABKSRVRQ-UUNJERMWSA-N 0.000 description 4
• 241000270322 Lepidosauria Species 0.000 description 4
• 206010024324 Leukaemias Diseases 0.000 description 4
• 210000004379 Membranes Anatomy 0.000 description 4
• 102000015636 Oligopeptides Human genes 0.000 description 4
• 108010038807 Oligopeptides Proteins 0.000 description 4
• 241000283973 Oryctolagus cuniculus Species 0.000 description 4
• 235000003534 Saccharomyces carlsbergensis Nutrition 0.000 description 4
• 229940081969 Saccharomyces cerevisiae Drugs 0.000 description 4
• 239000004473 Threonine Substances 0.000 description 4
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 4
• 125000000539 amino acid group Chemical group 0.000 description 4
• 229910000019 calcium carbonate Inorganic materials 0.000 description 4
• 235000010216 calcium carbonate Nutrition 0.000 description 4
• 150000001720 carbohydrates Chemical class 0.000 description 4
• 235000014633 carbohydrates Nutrition 0.000 description 4
• 230000024881 catalytic activity Effects 0.000 description 4
• 230000022131 cell cycle Effects 0.000 description 4
• 230000002950 deficient Effects 0.000 description 4
• 230000002939 deleterious Effects 0.000 description 4
• 239000003085 diluting agent Substances 0.000 description 4
• 230000001605 fetal Effects 0.000 description 4
• 230000002209 hydrophobic Effects 0.000 description 4
• 230000001939 inductive effect Effects 0.000 description 4
• 230000009027 insemination Effects 0.000 description 4
• 229960000318 kanamycin Drugs 0.000 description 4
• 239000008101 lactose Substances 0.000 description 4
• GUBGYTABKSRVRQ-XLOQQCSPSA-N lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 4
• 239000002502 liposome Substances 0.000 description 4
• 238000005259 measurement Methods 0.000 description 4
• 238000000691 measurement method Methods 0.000 description 4
• 238000002844 melting Methods 0.000 description 4
• 238000001823 molecular biology technique Methods 0.000 description 4
• 201000000050 myeloid neoplasm Diseases 0.000 description 4
• 230000001264 neutralization Effects 0.000 description 4
• 150000007524 organic acids Chemical class 0.000 description 4
• 101700023985 pol3 Proteins 0.000 description 4
• 238000006116 polymerization reaction Methods 0.000 description 4
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 4
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
• KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Inorganic materials [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 4
• LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
• 230000002335 preservative Effects 0.000 description 4
• 239000003755 preservative agent Substances 0.000 description 4
• 230000002062 proliferating Effects 0.000 description 4
• DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 4
• 230000001603 reducing Effects 0.000 description 4
• 230000003584 silencer Effects 0.000 description 4
• 229910052708 sodium Inorganic materials 0.000 description 4
• 229910001415 sodium ion Inorganic materials 0.000 description 4
• 239000003381 stabilizer Substances 0.000 description 4
• 238000010186 staining Methods 0.000 description 4
• 230000002459 sustained Effects 0.000 description 4
• 230000001052 transient Effects 0.000 description 4
• RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 4
• XSQUKJJJFZCRTK-UHFFFAOYSA-N urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
• 239000011534 wash buffer Substances 0.000 description 4
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
• 229920001817 Agar Polymers 0.000 description 3
• BFNBIHQBYMNNAN-UHFFFAOYSA-N Ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
• 208000007502 Anemia Diseases 0.000 description 3
• 206010003210 Arteriosclerosis Diseases 0.000 description 3
• 241000283153 Cetacea Species 0.000 description 3
• 229920001405 Coding region Polymers 0.000 description 3
• 206010009944 Colon cancer Diseases 0.000 description 3
• 241000192700 Cyanobacteria Species 0.000 description 3
• 229940104302 Cytosine Drugs 0.000 description 3
• 108010014080 DNA Polymerase gamma Proteins 0.000 description 3
• 102000016903 DNA Polymerase gamma Human genes 0.000 description 3
• 206010012289 Dementia Diseases 0.000 description 3
• 238000002965 ELISA Methods 0.000 description 3
• 229940093915 Gynecological Organic acids Drugs 0.000 description 3
• 102000001554 Hemoglobins Human genes 0.000 description 3
• 108010054147 Hemoglobins Proteins 0.000 description 3
• 208000006454 Hepatitis Diseases 0.000 description 3
• 240000005979 Hordeum vulgare Species 0.000 description 3
• 235000007340 Hordeum vulgare Nutrition 0.000 description 3
• 229940088597 Hormone Drugs 0.000 description 3
• 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 3
• 241000235789 Hyperoartia Species 0.000 description 3
• 102000018358 Immunoglobulins Human genes 0.000 description 3
• 108060003951 Immunoglobulins Proteins 0.000 description 3
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 3
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 3
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 3
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 3
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
• 210000004185 Liver Anatomy 0.000 description 3
• 241001460678 Napo <wasp> Species 0.000 description 3
• 210000003101 Oviducts Anatomy 0.000 description 3
• 210000004681 Ovum Anatomy 0.000 description 3
• XAPRFLSJBSXESP-UHFFFAOYSA-N Oxycinchophen Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=C(O)C=1C1=CC=CC=C1 XAPRFLSJBSXESP-UHFFFAOYSA-N 0.000 description 3
• 229920002224 Peptide nucleic acid Polymers 0.000 description 3
• 229960005190 Phenylalanine Drugs 0.000 description 3
• 208000008425 Protein Deficiency Diseases 0.000 description 3
• 206010038428 Renal disease Diseases 0.000 description 3
• 210000002863 Seminiferous Tubules Anatomy 0.000 description 3
• RMAQACBXLXPBSY-UHFFFAOYSA-N Silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 3
• 240000003829 Sorghum propinquum Species 0.000 description 3
• 235000011684 Sorghum saccharatum Nutrition 0.000 description 3
• QORWJWZARLRLPR-UHFFFAOYSA-H Tricalcium phosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
• 241000700605 Viruses Species 0.000 description 3
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Vitamin C Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
• 238000010521 absorption reaction Methods 0.000 description 3
• 238000009825 accumulation Methods 0.000 description 3
• QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
• 239000000654 additive Substances 0.000 description 3
• 239000008272 agar Substances 0.000 description 3
• 150000001298 alcohols Chemical class 0.000 description 3
• 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
• 235000011130 ammonium sulphate Nutrition 0.000 description 3
• 230000000890 antigenic Effects 0.000 description 3
• 239000003963 antioxidant agent Substances 0.000 description 3
• 235000006708 antioxidants Nutrition 0.000 description 3
• 239000007864 aqueous solution Substances 0.000 description 3
• 235000010323 ascorbic acid Nutrition 0.000 description 3
• 239000011668 ascorbic acid Substances 0.000 description 3
• 229960005070 ascorbic acid Drugs 0.000 description 3
• 230000001580 bacterial Effects 0.000 description 3
• 239000001506 calcium phosphate Substances 0.000 description 3
• 229910000389 calcium phosphate Inorganic materials 0.000 description 3
• 235000011010 calcium phosphates Nutrition 0.000 description 3
• 230000000711 cancerogenic Effects 0.000 description 3
• 239000001768 carboxy methyl cellulose Substances 0.000 description 3
• 231100000315 carcinogenic Toxicity 0.000 description 3
• 238000004113 cell culture Methods 0.000 description 3
• 239000003153 chemical reaction reagent Substances 0.000 description 3
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
• 239000003086 colorant Substances 0.000 description 3
• 210000004748 cultured cells Anatomy 0.000 description 3
• 238000001514 detection method Methods 0.000 description 3
• 235000014113 dietary fatty acids Nutrition 0.000 description 3
• 108060002322 dnaE2 Proteins 0.000 description 3
• 238000010195 expression analysis Methods 0.000 description 3
• 239000000284 extract Substances 0.000 description 3
• 239000000194 fatty acid Substances 0.000 description 3
• 150000004665 fatty acids Chemical class 0.000 description 3
• 239000000796 flavoring agent Substances 0.000 description 3
• 238000009472 formulation Methods 0.000 description 3
• 108020001507 fusion proteins Proteins 0.000 description 3
• 102000037240 fusion proteins Human genes 0.000 description 3
• 235000011187 glycerol Nutrition 0.000 description 3
• 235000014304 histidine Nutrition 0.000 description 3
• 239000005556 hormone Substances 0.000 description 3
• 239000001257 hydrogen Substances 0.000 description 3
• 229910052739 hydrogen Inorganic materials 0.000 description 3
• 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 3
• 239000001863 hydroxypropyl cellulose Substances 0.000 description 3
• 229940071676 hydroxypropylcellulose Drugs 0.000 description 3
• 238000003018 immunoassay Methods 0.000 description 3
• 230000000984 immunochemical Effects 0.000 description 3
• 230000002401 inhibitory effect Effects 0.000 description 3
• 230000003834 intracellular Effects 0.000 description 3
• 238000001990 intravenous administration Methods 0.000 description 3
• 150000002632 lipids Chemical class 0.000 description 3
• 201000009673 liver disease Diseases 0.000 description 3
• 230000000877 morphologic Effects 0.000 description 3
• 210000000653 nervous system Anatomy 0.000 description 3
• 210000002569 neurons Anatomy 0.000 description 3
• 229910052757 nitrogen Inorganic materials 0.000 description 3
• 235000005985 organic acids Nutrition 0.000 description 3
• 244000045947 parasites Species 0.000 description 3
• 230000002093 peripheral Effects 0.000 description 3
• 230000037048 polymerization activity Effects 0.000 description 3
• 238000001556 precipitation Methods 0.000 description 3
• 230000035935 pregnancy Effects 0.000 description 3
• 235000013930 proline Nutrition 0.000 description 3
• BDERNNFJNOPAEC-UHFFFAOYSA-N propanol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
• XBDQKXXYIPTUBI-UHFFFAOYSA-N propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 3
• 238000000746 purification Methods 0.000 description 3
• 239000012521 purified sample Substances 0.000 description 3
• 238000011084 recovery Methods 0.000 description 3
• 230000003362 replicative Effects 0.000 description 3
• 239000000523 sample Substances 0.000 description 3
• 101710008211 sbcB Proteins 0.000 description 3
• 235000012239 silicon dioxide Nutrition 0.000 description 3
• KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
• FKNQFGJONOIPTF-UHFFFAOYSA-N sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 3
• HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
• 239000001488 sodium phosphate Substances 0.000 description 3
• 229910000162 sodium phosphate Inorganic materials 0.000 description 3
• 235000000346 sugar Nutrition 0.000 description 3
• 239000000829 suppository Substances 0.000 description 3
• 230000004083 survival Effects 0.000 description 3
• 239000000375 suspending agent Substances 0.000 description 3
• 239000000725 suspension Substances 0.000 description 3
• 238000010361 transduction Methods 0.000 description 3
• 230000026683 transduction Effects 0.000 description 3
• HVYWMOMLDIMFJA-DPAQBDIFSA-N (3β)-Cholest-5-en-3-ol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
• KRKNYBCHXYNGOX-UHFFFAOYSA-K 2qpq Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
• HJFCVJKLGPYQDB-UHFFFAOYSA-N 5-(4-aminophenyl)cyclohexa-2,4-diene-1,1,2-triamine Chemical compound C1C(N)(N)C(N)=CC=C1C1=CC=C(N)C=C1 HJFCVJKLGPYQDB-UHFFFAOYSA-N 0.000 description 2
• 235000005254 Allium ampeloprasum Nutrition 0.000 description 2
• 240000006108 Allium ampeloprasum Species 0.000 description 2
• 239000005995 Aluminium silicate Substances 0.000 description 2
• PZZYQPZGQPZBDN-UHFFFAOYSA-N Aluminium silicate Chemical compound O=[Al]O[Si](=O)O[Al]=O PZZYQPZGQPZBDN-UHFFFAOYSA-N 0.000 description 2
• AVKUERGKIZMTKX-NJBDSQKTSA-N Ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
• 206010002967 Aplastic anaemia Diseases 0.000 description 2
• 241000193830 Bacillus <bacterium> Species 0.000 description 2
• 210000002469 Basement Membrane Anatomy 0.000 description 2
• 229960000686 Benzalkonium Chloride Drugs 0.000 description 2
• SESFRYSPDFLNCH-UHFFFAOYSA-N Benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
• 210000004369 Blood Anatomy 0.000 description 2
• 210000000601 Blood Cells Anatomy 0.000 description 2
• 241000255789 Bombyx mori Species 0.000 description 2
• 240000007124 Brassica oleracea Species 0.000 description 2
• 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 2
• 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 2
• 235000017647 Brassica oleracea var italica Nutrition 0.000 description 2
• 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 2
• 240000003259 Brassica oleracea var. botrytis Species 0.000 description 2
• 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 description 2
• 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 description 2
• 241000499436 Brassica rapa subsp. pekinensis Species 0.000 description 2
• 239000012619 Butyl Sepharose® Substances 0.000 description 2
• 229940041514 Candida albicans extract Drugs 0.000 description 2
• 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
• 229940105329 Carboxymethylcellulose Drugs 0.000 description 2
• 208000005623 Carcinogenesis Diseases 0.000 description 2
• 241001466804 Carnivora Species 0.000 description 2
• 210000003169 Central Nervous System Anatomy 0.000 description 2
• 241000282693 Cercopithecidae Species 0.000 description 2
• 241000207199 Citrus Species 0.000 description 2
• 210000001072 Colon Anatomy 0.000 description 2
• 241000219112 Cucumis Species 0.000 description 2
• 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 2
• 240000008067 Cucumis sativus Species 0.000 description 2
• 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 2
• 241000219104 Cucurbitaceae Species 0.000 description 2
• GZCGUPFRVQAUEE-KCDKBNATSA-N D-(+)-Galactose Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-KCDKBNATSA-N 0.000 description 2
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical class OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
• 108010041052 DNA Topoisomerase IV Proteins 0.000 description 2
• 238000000018 DNA microarray Methods 0.000 description 2
• 108010032250 DNA polymerase beta2 Proteins 0.000 description 2
• 230000027289 DNA replication proofreading Effects 0.000 description 2
• 240000002860 Daucus carota Species 0.000 description 2
• 235000002243 Daucus carota subsp sativus Nutrition 0.000 description 2
• 239000004375 Dextrin Substances 0.000 description 2
• 229920001353 Dextrin Polymers 0.000 description 2
• 102000016607 Diphtheria Toxin Human genes 0.000 description 2
• 108010053187 Diphtheria Toxin Proteins 0.000 description 2
• 210000003981 Ectoderm Anatomy 0.000 description 2
• 210000001900 Endoderm Anatomy 0.000 description 2
• 210000000981 Epithelium Anatomy 0.000 description 2
• 241000283073 Equus caballus Species 0.000 description 2
• 210000001508 Eye Anatomy 0.000 description 2
• 241000272184 Falconiformes Species 0.000 description 2
• BJHIKXHVCXFQLS-UYFOZJQFSA-N Fructose Natural products OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 2
• 102100004985 GUSB Human genes 0.000 description 2
• 108010060309 Glucuronidase Proteins 0.000 description 2
• UYTPUPDQBNUYGX-UHFFFAOYSA-N Guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
• VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
• 210000003958 Hematopoietic Stem Cells Anatomy 0.000 description 2
• 210000000003 Hoof Anatomy 0.000 description 2
• 229940084986 Human Chorionic Gonadotropin Drugs 0.000 description 2
• 210000004408 Hybridomas Anatomy 0.000 description 2
• 210000000987 Immune System Anatomy 0.000 description 2
• 102000004851 Immunoglobulin G Human genes 0.000 description 2
• 108090001095 Immunoglobulin G Proteins 0.000 description 2
• 108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 2
• 235000002678 Ipomoea batatas Nutrition 0.000 description 2
• 240000003613 Ipomoea batatas Species 0.000 description 2
• 206010023204 Joint dislocation Diseases 0.000 description 2
• 210000003734 Kidney Anatomy 0.000 description 2
• QANMHLXAZMSUEX-UHFFFAOYSA-N Kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 description 2
• 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
• 206010025323 Lymphomas Diseases 0.000 description 2
• 241000218922 Magnoliophyta Species 0.000 description 2
• 210000002901 Mesenchymal Stem Cells Anatomy 0.000 description 2
• 210000003716 Mesoderm Anatomy 0.000 description 2
• 241000289419 Metatheria Species 0.000 description 2
• GNSKLFRGEWLPPA-UHFFFAOYSA-M Monopotassium phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 2
• 208000010125 Myocardial Infarction Diseases 0.000 description 2
• 241000244206 Nematoda Species 0.000 description 2
• 206010028980 Neoplasm Diseases 0.000 description 2
• 206010029151 Nephropathy Diseases 0.000 description 2
• 210000001178 Neural Stem Cells Anatomy 0.000 description 2
• 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
• 240000008962 Nicotiana tabacum Species 0.000 description 2
• 210000004940 Nucleus Anatomy 0.000 description 2
• 101700050167 OlnB1 Proteins 0.000 description 2
• 210000003463 Organelles Anatomy 0.000 description 2
• 206010025310 Other lymphomas Diseases 0.000 description 2
• 102100012459 POLL Human genes 0.000 description 2
• 229940049954 Penicillin Drugs 0.000 description 2
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
• 241000209504 Poaceae Species 0.000 description 2
• 238000004617 QSAR study Methods 0.000 description 2
• 108010091086 Recombinases Proteins 0.000 description 2
• 102000018120 Recombinases Human genes 0.000 description 2
• 108020005091 Replication Origin Proteins 0.000 description 2
• 229920001914 Ribonucleotide Polymers 0.000 description 2
• 210000002966 Serum Anatomy 0.000 description 2
• 108010071390 Serum Albumin Proteins 0.000 description 2
• 102000007562 Serum Albumin Human genes 0.000 description 2
• 240000003768 Solanum lycopersicum Species 0.000 description 2
• 235000002597 Solanum melongena Nutrition 0.000 description 2
• 240000002686 Solanum melongena Species 0.000 description 2
• 235000019764 Soybean Meal Nutrition 0.000 description 2
• QIQXTHQIDYTFRH-UHFFFAOYSA-N Stearic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
• 229960005322 Streptomycin Drugs 0.000 description 2
• QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
• 241000282898 Sus scrofa Species 0.000 description 2
• 108091008153 T cell receptors Proteins 0.000 description 2
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 2
• RWQNBRDOKXIBIV-UHFFFAOYSA-N Thymine Chemical group CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
• AOBORMOPSGHCAX-DGHZZKTQSA-N Tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 2
• 108090000631 Trypsin Proteins 0.000 description 2
• 102000004142 Trypsin Human genes 0.000 description 2
• 108010046308 Type II DNA Topoisomerases Proteins 0.000 description 2
• 102000007537 Type II DNA Topoisomerases Human genes 0.000 description 2
• 229940035893 Uracil Drugs 0.000 description 2
• 210000004291 Uterus Anatomy 0.000 description 2
• 235000005042 Zier Kohl Nutrition 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
• 238000002835 absorbance Methods 0.000 description 2
• 238000006640 acetylation reaction Methods 0.000 description 2
• 150000007513 acids Chemical class 0.000 description 2
• GFFGJBXGBJISGV-UHFFFAOYSA-N adenyl group Chemical group N1=CN=C2N=CNC2=C1N GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
• 239000003463 adsorbent Substances 0.000 description 2
• 231100000494 adverse effect Toxicity 0.000 description 2
• 239000002168 alkylating agent Substances 0.000 description 2
• 229940087168 alpha Tocopherol Drugs 0.000 description 2
• GVJHHUAWPYXKBD-IEOSBIPESA-N alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
• 235000012211 aluminium silicate Nutrition 0.000 description 2
• QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
• 229960000723 ampicillin Drugs 0.000 description 2
• 238000005571 anion exchange chromatography Methods 0.000 description 2
• 230000000111 anti-oxidant Effects 0.000 description 2
• 235000019445 benzyl alcohol Nutrition 0.000 description 2
• 229960000626 benzylpenicillin Drugs 0.000 description 2
• 239000011230 binding agent Substances 0.000 description 2
• 239000003181 biological factor Substances 0.000 description 2
• 239000008280 blood Substances 0.000 description 2
• 230000036952 cancer formation Effects 0.000 description 2
• 239000002775 capsule Substances 0.000 description 2
• 239000004202 carbamide Substances 0.000 description 2
• OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
• 229910052799 carbon Inorganic materials 0.000 description 2
• 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
• 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
• 231100000504 carcinogenesis Toxicity 0.000 description 2
• 239000003054 catalyst Substances 0.000 description 2
• 238000005277 cation exchange chromatography Methods 0.000 description 2
• 230000024245 cell differentiation Effects 0.000 description 2
• 230000010261 cell growth Effects 0.000 description 2
• 229920002678 cellulose Polymers 0.000 description 2
• 239000001913 cellulose Substances 0.000 description 2
• 235000010980 cellulose Nutrition 0.000 description 2
• HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
• 235000019804 chlorophyll Nutrition 0.000 description 2
• ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
• 229930002875 chlorophylls Natural products 0.000 description 2
• 238000011098 chromatofocusing Methods 0.000 description 2
• 235000020971 citrus fruits Nutrition 0.000 description 2
• 238000005037 combinatorial chemistry Methods 0.000 description 2
• 230000001143 conditioned Effects 0.000 description 2
• 239000000470 constituent Substances 0.000 description 2
• 230000003247 decreasing Effects 0.000 description 2
• 201000004624 dermatitis Diseases 0.000 description 2
• 238000011033 desalting Methods 0.000 description 2
• 235000019425 dextrin Nutrition 0.000 description 2
• 210000002249 digestive system Anatomy 0.000 description 2
• 239000007884 disintegrant Substances 0.000 description 2
• 101710028984 dnaQ Proteins 0.000 description 2
• 230000005611 electricity Effects 0.000 description 2
• 238000001962 electrophoresis Methods 0.000 description 2
• 108091005938 enhanced green fluorescent protein Proteins 0.000 description 2
• 238000001976 enzyme digestion Methods 0.000 description 2
• 150000002148 esters Chemical class 0.000 description 2
• 238000011156 evaluation Methods 0.000 description 2
• 238000000605 extraction Methods 0.000 description 2
• 239000012091 fetal bovine serum Substances 0.000 description 2
• 210000002950 fibroblast Anatomy 0.000 description 2
• 235000019634 flavors Nutrition 0.000 description 2
• 235000013305 food Nutrition 0.000 description 2
• 235000003599 food sweetener Nutrition 0.000 description 2
• WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
• 238000005755 formation reaction Methods 0.000 description 2
• 238000002523 gelfiltration Methods 0.000 description 2
• 230000035784 germination Effects 0.000 description 2
• 239000011521 glass Substances 0.000 description 2
• 230000003899 glycosylation Effects 0.000 description 2
• 238000006206 glycosylation reaction Methods 0.000 description 2
• 229910001385 heavy metal Inorganic materials 0.000 description 2
• 231100000283 hepatitis Toxicity 0.000 description 2
• 238000004128 high performance liquid chromatography Methods 0.000 description 2
• 239000003906 humectant Substances 0.000 description 2
• MHAJPDPJQMAIIY-UHFFFAOYSA-N hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
• 229920001477 hydrophilic polymer Polymers 0.000 description 2
• 230000001900 immune effect Effects 0.000 description 2
• 230000002163 immunogen Effects 0.000 description 2
• 230000002055 immunohistochemical Effects 0.000 description 2
• 239000007943 implant Substances 0.000 description 2
• 238000010348 incorporation Methods 0.000 description 2
• 239000003112 inhibitor Substances 0.000 description 2
• 238000003780 insertion Methods 0.000 description 2
• 230000003993 interaction Effects 0.000 description 2
• 238000007918 intramuscular administration Methods 0.000 description 2
• 238000007914 intraventricular administration Methods 0.000 description 2
• 230000002427 irreversible Effects 0.000 description 2
• 238000001155 isoelectric focusing Methods 0.000 description 2
• 238000002955 isolation Methods 0.000 description 2
• 210000003292 kidney cell Anatomy 0.000 description 2
• 201000006370 kidney failure Diseases 0.000 description 2
• 230000001665 lethal Effects 0.000 description 2
• 231100000518 lethal Toxicity 0.000 description 2
• 101710030587 ligN Proteins 0.000 description 2
• 101700077585 ligd Proteins 0.000 description 2
• 200000000011 liver disorder Diseases 0.000 description 2
• 239000000314 lubricant Substances 0.000 description 2
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
• 210000004962 mammalian cells Anatomy 0.000 description 2
• 235000013372 meat Nutrition 0.000 description 2
• 230000021121 meiosis Effects 0.000 description 2
• OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
• 229920000609 methyl cellulose Polymers 0.000 description 2
• DWCZIOOZPIDHAB-UHFFFAOYSA-L methyl green Chemical compound [Cl-].[Cl-].C1=CC(N(C)C)=CC=C1C(C=1C=CC(=CC=1)[N+](C)(C)C)=C1C=CC(=[N+](C)C)C=C1 DWCZIOOZPIDHAB-UHFFFAOYSA-L 0.000 description 2
• 235000010981 methylcellulose Nutrition 0.000 description 2
• 239000001923 methylcellulose Substances 0.000 description 2
• YACKEPLHDIMKIO-UHFFFAOYSA-L methylphosphonate(2-) Chemical compound CP([O-])([O-])=O YACKEPLHDIMKIO-UHFFFAOYSA-L 0.000 description 2
• CSNNHWWHGAXBCP-UHFFFAOYSA-L mgso4 Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
• 238000002493 microarray Methods 0.000 description 2
• 150000007522 mineralic acids Chemical class 0.000 description 2
• 238000002156 mixing Methods 0.000 description 2
• 239000002808 molecular sieve Substances 0.000 description 2
• 108010045030 monoclonal antibodies Proteins 0.000 description 2
• 102000005614 monoclonal antibodies Human genes 0.000 description 2
• 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
• 235000019796 monopotassium phosphate Nutrition 0.000 description 2
• 150000002772 monosaccharides Chemical class 0.000 description 2
• PVNIIMVLHYAWGP-UHFFFAOYSA-N nicotinic acid Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
• MWUXSHHQAYIFBG-UHFFFAOYSA-N nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
• 238000007899 nucleic acid hybridization Methods 0.000 description 2
• 239000003921 oil Substances 0.000 description 2
• 235000019198 oils Nutrition 0.000 description 2
• 238000002515 oligonucleotide synthesis Methods 0.000 description 2
• 238000004806 packaging method and process Methods 0.000 description 2
• 229920002866 paraformaldehyde Polymers 0.000 description 2
• 230000000849 parathyroid Effects 0.000 description 2
• 238000007911 parenteral administration Methods 0.000 description 2
• 239000002245 particle Substances 0.000 description 2
• 230000001717 pathogenic Effects 0.000 description 2
• 244000052769 pathogens Species 0.000 description 2
• 239000000825 pharmaceutical preparation Substances 0.000 description 2
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
• 239000010452 phosphate Substances 0.000 description 2
• 238000006366 phosphorylation reaction Methods 0.000 description 2
• 230000000865 phosphorylative Effects 0.000 description 2
• 239000006187 pill Substances 0.000 description 2
• 239000003375 plant hormone Substances 0.000 description 2
• 238000004161 plant tissue culture Methods 0.000 description 2
• 230000004260 plant-type cell wall biogenesis Effects 0.000 description 2
• 229920001983 poloxamer Polymers 0.000 description 2
• 239000011148 porous material Substances 0.000 description 2
• 230000035755 proliferation Effects 0.000 description 2
• 238000010839 reverse transcription Methods 0.000 description 2
• 238000003757 reverse transcription PCR Methods 0.000 description 2
• 239000002336 ribonucleotide Substances 0.000 description 2
• 238000005185 salting out Methods 0.000 description 2
• 239000006152 selective media Substances 0.000 description 2
• 231100000486 side effect Toxicity 0.000 description 2
• CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
• 238000000638 solvent extraction Methods 0.000 description 2
• 239000004455 soybean meal Substances 0.000 description 2
• 238000007447 staining method Methods 0.000 description 2
• 238000007920 subcutaneous administration Methods 0.000 description 2
• 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 2
• 239000004094 surface-active agent Substances 0.000 description 2
• 238000001356 surgical procedure Methods 0.000 description 2
• 239000003765 sweetening agent Substances 0.000 description 2
• 230000001225 therapeutic Effects 0.000 description 2
• 238000002560 therapeutic procedure Methods 0.000 description 2
• 229960000984 tocofersolan Drugs 0.000 description 2
• 108090000464 transcription factors Proteins 0.000 description 2
• 102000003995 transcription factors Human genes 0.000 description 2
• 230000002103 transcriptional Effects 0.000 description 2
• 238000001890 transfection Methods 0.000 description 2
• 229960001322 trypsin Drugs 0.000 description 2
• 239000012588 trypsin Substances 0.000 description 2
• 230000002792 vascular Effects 0.000 description 2
• 239000003981 vehicle Substances 0.000 description 2
• 239000008215 water for injection Substances 0.000 description 2
• 235000005765 wild carrot Nutrition 0.000 description 2
• 239000012138 yeast extract Substances 0.000 description 2
• 239000002076 α-tocopherol Substances 0.000 description 2
• 235000004835 α-tocopherol Nutrition 0.000 description 2
• LNAZSHAWQACDHT-XIYTZBAFSA-N (2R,3R,4S,5R,6S)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2S,3R,4S,5R,6R)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2R,3R,4S,5R,6R)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
• XZWYTXMRWQJBGX-VXBMVYAYSA-N (2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-amino-3-carboxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]hexanoyl]amino]-3-carboxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-carbox Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(O)=O)CC1=CC=C(O)C=C1 XZWYTXMRWQJBGX-VXBMVYAYSA-N 0.000 description 1
• DBTMGCOVALSLOR-DEVYUCJPSA-N (2S,3R,4S,5R,6R)-4-[(2S,3R,4S,5R,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](CO)O[C@H](O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-DEVYUCJPSA-N 0.000 description 1
• PLVPPLCLBIEYEA-AATRIKPKSA-N (E)-3-(1H-indol-3-yl)prop-2-enoic acid Chemical compound C1=CC=C2C(/C=C/C(=O)O)=CNC2=C1 PLVPPLCLBIEYEA-AATRIKPKSA-N 0.000 description 1
• JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
• FVPXJPVSJNSJBL-UHFFFAOYSA-N 1H-pyrimidine-2,4-dione;1,3-thiazole Chemical compound C1=CSC=N1.O=C1C=CNC(=O)N1 FVPXJPVSJNSJBL-UHFFFAOYSA-N 0.000 description 1
• VGONTNSXDCQUGY-RRKCRQDMSA-N 2'-deoxyinosine Chemical group C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC2=O)=C2N=C1 VGONTNSXDCQUGY-RRKCRQDMSA-N 0.000 description 1
• BVDRUCCQKHGCRX-UHFFFAOYSA-N 2,3-dihydroxypropyl formate Chemical compound OCC(O)COC=O BVDRUCCQKHGCRX-UHFFFAOYSA-N 0.000 description 1
• 239000005631 2,4-D Substances 0.000 description 1
• YLTNWAQTQJRBKR-UHFFFAOYSA-N 2,5-diamino-2-methyl-5-oxopentanoic acid Chemical compound OC(=O)C(N)(C)CCC(N)=O YLTNWAQTQJRBKR-UHFFFAOYSA-N 0.000 description 1
• DJYVEBBGKNAHKE-UHFFFAOYSA-N 2-(azaniumylmethyl)-3-phenylpropanoate Chemical compound NCC(C(O)=O)CC1=CC=CC=C1 DJYVEBBGKNAHKE-UHFFFAOYSA-N 0.000 description 1
• WJYAJBDKANFOID-UHFFFAOYSA-N 2-(dodecylamino)propanoic acid Chemical compound CCCCCCCCCCCCNC(C)C(O)=O WJYAJBDKANFOID-UHFFFAOYSA-N 0.000 description 1
• VUKAUDKDFVSVFT-UHFFFAOYSA-N 2-[6-[4,5-bis(2-hydroxypropoxy)-2-(2-hydroxypropoxymethyl)-6-methoxyoxan-3-yl]oxy-4,5-dimethoxy-2-(methoxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)-5-methoxyoxane-3,4-diol Chemical compound COC1C(OC)C(OC2C(C(O)C(OC)C(CO)O2)O)C(COC)OC1OC1C(COCC(C)O)OC(OC)C(OCC(C)O)C1OCC(C)O VUKAUDKDFVSVFT-UHFFFAOYSA-N 0.000 description 1
• YGZFYDFBHIDIBH-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]icosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCC(CO)N(CCO)CCO YGZFYDFBHIDIBH-UHFFFAOYSA-N 0.000 description 1
• LENZDBCJOHFCAS-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
• DGVVWUTYPXICAM-UHFFFAOYSA-N 2-mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
• 238000005084 2D-nuclear magnetic resonance Methods 0.000 description 1
• PGRHXDWITVMQBC-UHFFFAOYSA-N 3-acetyl-6-methylpyran-2,4-dione Chemical compound CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
• XWHHYOYVRVGJJY-QMMMGPOBSA-N 4-fluorophenyl-L-alanine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(F)C=C1 XWHHYOYVRVGJJY-QMMMGPOBSA-N 0.000 description 1
• CWSZBVAUYPTXTG-UHFFFAOYSA-N 5-[6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxy-5-[4-hydroxy-3-(2-hydroxyethoxy)-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol Chemical compound O1C(CO)C(OC)C(O)C(O)C1OCC1C(OC2C(C(O)C(OC)C(CO)O2)OCCO)C(O)C(O)C(OC2C(OC(C)C(O)C2O)CO)O1 CWSZBVAUYPTXTG-UHFFFAOYSA-N 0.000 description 1
• UJBCLAXPPIDQEE-UHFFFAOYSA-N 5-prop-1-ynyl-1H-pyrimidine-2,4-dione Chemical group CC#CC1=CNC(=O)NC1=O UJBCLAXPPIDQEE-UHFFFAOYSA-N 0.000 description 1
• 101700084127 AVP Proteins 0.000 description 1
• 102100017238 AVP Human genes 0.000 description 1
• 206010059625 Abdominal wall disease Diseases 0.000 description 1
• 241001143500 Aceraceae Species 0.000 description 1
• 241000186361 Actinobacteria <class> Species 0.000 description 1
• 206010000880 Acute myeloid leukaemia Diseases 0.000 description 1
• 208000005641 Adenomyosis Diseases 0.000 description 1
• 102000011690 Adiponectin Human genes 0.000 description 1
• 108010076365 Adiponectin Proteins 0.000 description 1
• 210000004404 Adrenal Cortex Anatomy 0.000 description 1
• 229940023476 Agar Drugs 0.000 description 1
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
• 239000005695 Ammonium acetate Substances 0.000 description 1
• NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
• 239000004254 Ammonium phosphate Substances 0.000 description 1
• 244000144730 Amygdalus persica Species 0.000 description 1
• 206010002329 Aneurysm Diseases 0.000 description 1
• 206010002383 Angina pectoris Diseases 0.000 description 1
• 241000252073 Anguilliformes Species 0.000 description 1
• 108010055216 Anti-Idiotypic Antibodies Proteins 0.000 description 1
• 206010003119 Arrhythmia Diseases 0.000 description 1
• 206010060963 Arterial disease Diseases 0.000 description 1
• 241000238421 Arthropoda Species 0.000 description 1
• 241000972773 Aulopiformes Species 0.000 description 1
• 108060000884 BCKDHA Proteins 0.000 description 1
• 102100018813 BCKDHA Human genes 0.000 description 1
• 108010062877 Bacteriocins Proteins 0.000 description 1
• 229960001950 Benzethonium Chloride Drugs 0.000 description 1
• UREZNYTWGJKWBI-UHFFFAOYSA-M Benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
• 206010061008 Biliary tract disease Diseases 0.000 description 1
• 230000036912 Bioavailability Effects 0.000 description 1
• 206010005003 Bladder cancer Diseases 0.000 description 1
• 208000002352 Blister Diseases 0.000 description 1
• 210000004204 Blood Vessels Anatomy 0.000 description 1
• 210000001185 Bone Marrow Anatomy 0.000 description 1
• KGBXLFKZBHKPEV-UHFFFAOYSA-N Boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
• 208000003174 Brain Neoplasms Diseases 0.000 description 1
• 241000219193 Brassicaceae Species 0.000 description 1
• 241000186146 Brevibacterium Species 0.000 description 1
• 206010064913 Bronchial disease Diseases 0.000 description 1
• 229940084030 CARBOXYMETHYLCELLULOSE CALCIUM Drugs 0.000 description 1
• 101700051654 CDK1 Proteins 0.000 description 1
• 101700048555 CDK2 Proteins 0.000 description 1
• 101710022231 CDK2AP1 Proteins 0.000 description 1
• 101700066277 COS-1 Proteins 0.000 description 1
• CJZGTCYPCWQAJB-UHFFFAOYSA-L Calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
• FSBIGDSBMBYOPN-VKHMYHEASA-N Canavanine Chemical compound OC(=O)[C@@H](N)CCONC(N)=N FSBIGDSBMBYOPN-VKHMYHEASA-N 0.000 description 1
• 241000282472 Canis lupus familiaris Species 0.000 description 1
• 235000002566 Capsicum Nutrition 0.000 description 1
• 240000004160 Capsicum annuum Species 0.000 description 1
• 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
• FPPNZSSZRUTDAP-UWFZAAFLSA-N Carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
• 229960003669 Carbenicillin Drugs 0.000 description 1
• BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate dianion Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
• 206010007521 Cardiac arrhythmias Diseases 0.000 description 1
• 206010007554 Cardiac failure Diseases 0.000 description 1
• 208000005846 Cardiomyopathy Diseases 0.000 description 1
• 208000008787 Cardiovascular Disease Diseases 0.000 description 1
• 241000701489 Cauliflower mosaic virus Species 0.000 description 1
• 210000002421 Cell Wall Anatomy 0.000 description 1
• 206010008118 Cerebral infarction Diseases 0.000 description 1
• 210000001175 Cerebrospinal Fluid Anatomy 0.000 description 1
• 229940038705 Chlamydia trachomatis Drugs 0.000 description 1
• 241000606153 Chlamydia trachomatis Species 0.000 description 1
• OSASVXMJTNOKOY-UHFFFAOYSA-N Chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 1
• 229960004926 Chlorobutanol Drugs 0.000 description 1
• 241000282552 Chlorocebus aethiops Species 0.000 description 1
• 210000003763 Chloroplasts Anatomy 0.000 description 1
• 206010008631 Cholera Diseases 0.000 description 1
• 229940107161 Cholesterol Drugs 0.000 description 1
• 210000001612 Chondrocytes Anatomy 0.000 description 1
• 208000000668 Chronic Pancreatitis Diseases 0.000 description 1
• 206010008909 Chronic hepatitis Diseases 0.000 description 1
• 229920002759 Circular DNA Polymers 0.000 description 1
• 108020004638 Circular DNA Proteins 0.000 description 1
• 235000005602 Coleus parviflorus Nutrition 0.000 description 1
• 240000002347 Colocasia esculenta Species 0.000 description 1
• 108020004635 Complementary DNA Proteins 0.000 description 1
• 206010010539 Congenital megacolon Diseases 0.000 description 1
• 210000002808 Connective Tissue Anatomy 0.000 description 1
• 229960000355 Copper Sulfate Drugs 0.000 description 1
• ARUVKPQLZAKDPS-UHFFFAOYSA-L Copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
• 241000565118 Cordylophora caspia Species 0.000 description 1
• 210000004087 Cornea Anatomy 0.000 description 1
• 241000186216 Corynebacterium Species 0.000 description 1
• 241000699802 Cricetulus griseus Species 0.000 description 1
• 229960001681 Croscarmellose Sodium Drugs 0.000 description 1
• 229920002785 Croscarmellose sodium Polymers 0.000 description 1
• 206010011774 Cystic pancreatic disease Diseases 0.000 description 1
• 229960003067 Cystine Drugs 0.000 description 1
• 102000004127 Cytokines Human genes 0.000 description 1
• 108090000695 Cytokines Proteins 0.000 description 1
• 210000000805 Cytoplasm Anatomy 0.000 description 1
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
• WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
• COLNVLDHVKWLRT-MRVPVSSYSA-N D-phenylalanine Chemical compound OC(=O)[C@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-MRVPVSSYSA-N 0.000 description 1
• 108020001019 DNA Primers Proteins 0.000 description 1
• 102000011724 DNA Repair Enzymes Human genes 0.000 description 1
• 108010076525 DNA Repair Enzymes Proteins 0.000 description 1
• 108010061914 DNA polymerase mu Proteins 0.000 description 1
• 108010093204 DNA polymerase theta Proteins 0.000 description 1
• 239000003155 DNA primer Substances 0.000 description 1
• 230000033616 DNA repair Effects 0.000 description 1
• 238000001712 DNA sequencing Methods 0.000 description 1
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
• 241000252212 Danio rerio Species 0.000 description 1
• 239000004287 Dehydroacetic acid Substances 0.000 description 1
• 229920002307 Dextran Polymers 0.000 description 1
• 229960000633 Dextran Sulfate Drugs 0.000 description 1
• 206010012601 Diabetes mellitus Diseases 0.000 description 1
• 235000002722 Dioscorea batatas Nutrition 0.000 description 1
• 206010013023 Diphtheria Diseases 0.000 description 1
• ZPWVASYFFYYZEW-UHFFFAOYSA-L Dipotassium phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
• 241000255925 Diptera Species 0.000 description 1
• 108020004461 Double-Stranded RNA Proteins 0.000 description 1
• 102000013138 Drug Receptors Human genes 0.000 description 1
• 108010065556 Drug Receptors Proteins 0.000 description 1
• 206010052804 Drug tolerance Diseases 0.000 description 1
• 208000004418 Duodenal Disease Diseases 0.000 description 1
• 206010013883 Dwarfism Diseases 0.000 description 1
• 206010058314 Dysplasia Diseases 0.000 description 1
• 102000018251 EC 2.4.2.8 Human genes 0.000 description 1
• 108010091358 EC 2.4.2.8 Proteins 0.000 description 1
• 208000005679 Eczema Diseases 0.000 description 1
• 108010042407 Endonucleases Proteins 0.000 description 1
• 108010067770 Endopeptidase K Proteins 0.000 description 1
• 210000002889 Endothelial Cells Anatomy 0.000 description 1
• 241000283086 Equidae Species 0.000 description 1
• 241001452028 Escherichia coli DH1 Species 0.000 description 1
• 208000008754 Esophageal Disease Diseases 0.000 description 1
• 208000006168 Ewing Sarcoma Diseases 0.000 description 1
• 229920000665 Exon Polymers 0.000 description 1
• 210000003414 Extremities Anatomy 0.000 description 1
• 108010020195 FLAG peptide Proteins 0.000 description 1
• 101700077668 FTH1 Proteins 0.000 description 1
• 102100002026 FTH1 Human genes 0.000 description 1
• 206010016193 Fallot's tetralogy Diseases 0.000 description 1
• 210000003608 Feces Anatomy 0.000 description 1
• 208000001248 Female Genital Disease Diseases 0.000 description 1
• 208000007984 Female Infertility Diseases 0.000 description 1
• 108050000784 Ferritin Proteins 0.000 description 1
• 102000008857 Ferritin Human genes 0.000 description 1
• 238000008416 Ferritin Methods 0.000 description 1
• 229920001917 Ficoll Polymers 0.000 description 1
• IRXSLJNXXZKURP-UHFFFAOYSA-N Fluorenylmethyloxycarbonyl chloride Chemical compound C1=CC=C2C(COC(=O)Cl)C3=CC=CC=C3C2=C1 IRXSLJNXXZKURP-UHFFFAOYSA-N 0.000 description 1
• 206010017076 Fracture Diseases 0.000 description 1
• 235000016623 Fragaria vesca Nutrition 0.000 description 1
• 240000009088 Fragaria x ananassa Species 0.000 description 1
• 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
• 239000005715 Fructose Substances 0.000 description 1
• 206010017604 Galactosaemia Diseases 0.000 description 1
• IRSCQMHQWWYFCW-UHFFFAOYSA-N Ganciclovir Chemical compound O=C1NC(N)=NC2=C1N=CN2COC(CO)CO IRSCQMHQWWYFCW-UHFFFAOYSA-N 0.000 description 1
• 229960002963 Ganciclovir Drugs 0.000 description 1
• 206010017758 Gastric cancer Diseases 0.000 description 1
• 241000702463 Geminiviridae Species 0.000 description 1
• 206010064571 Gene mutation Diseases 0.000 description 1
• 210000001654 Germ Layers Anatomy 0.000 description 1
• 108010015899 Glycopeptides Proteins 0.000 description 1
• 102000002068 Glycopeptides Human genes 0.000 description 1
• 108020005128 Glycosidases Proteins 0.000 description 1
• 102000006771 Gonadotropins Human genes 0.000 description 1
• 108010086677 Gonadotropins Proteins 0.000 description 1
• 229940031574 HYDROXYMETHYL CELLULOSE Drugs 0.000 description 1
• 229940047650 Haemophilus influenzae Drugs 0.000 description 1
• 241000606768 Haemophilus influenzae Species 0.000 description 1
• 210000003780 Hair Follicle Anatomy 0.000 description 1
• 210000002216 Heart Anatomy 0.000 description 1
• 208000005304 Heart Septal Defects Diseases 0.000 description 1
• 206010019280 Heart failure Diseases 0.000 description 1
• 208000001258 Hemangiosarcoma Diseases 0.000 description 1
• 210000003494 Hepatocytes Anatomy 0.000 description 1
• 206010019909 Hernia Diseases 0.000 description 1
• 208000004592 Hirschsprung Disease Diseases 0.000 description 1
• 206010020118 Histiocytosis Diseases 0.000 description 1
• 206010020365 Homocystinuria Diseases 0.000 description 1
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
• 108091006822 Human Serum Albumin Proteins 0.000 description 1
• 102000008100 Human Serum Albumin Human genes 0.000 description 1
• 102000015434 Humanized Monoclonal Antibodies Human genes 0.000 description 1
• 108010064750 Humanized Monoclonal Antibodies Proteins 0.000 description 1
• 102000001974 Hyaluronidase Human genes 0.000 description 1
• 108010074224 Hyaluronoglucosaminidase Proteins 0.000 description 1
• 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
• 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
• 206010020578 Hyperbilirubinaemia Diseases 0.000 description 1
• 206010020772 Hypertension Diseases 0.000 description 1
• 206010020880 Hypertrophy Diseases 0.000 description 1
• 210000003016 Hypothalamus Anatomy 0.000 description 1
• 101710036245 IL4I1 Proteins 0.000 description 1
• 229940072221 IMMUNOGLOBULINS Drugs 0.000 description 1
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
• 229940027941 Immunoglobulin G Drugs 0.000 description 1
• 206010062018 Inborn error of metabolism Diseases 0.000 description 1
• 206010021928 Infertility female Diseases 0.000 description 1
• 206010022114 Injury Diseases 0.000 description 1
• 229960000367 Inositol Drugs 0.000 description 1
• CDAISMWEOUEBRE-GPIVLXJGSA-N Inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
• 210000004347 Intestinal Mucosa Anatomy 0.000 description 1
• 210000000936 Intestines Anatomy 0.000 description 1
• 229920002459 Intron Polymers 0.000 description 1
• BAUYGSIQEAFULO-UHFFFAOYSA-L Iron(II) sulfate Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
• 241000581650 Ivesia Species 0.000 description 1
• 241001507252 Japanese monkeys Species 0.000 description 1
• 239000007836 KH2PO4 Substances 0.000 description 1
• 108060005987 Kallikreins Proteins 0.000 description 1
• 102000001399 Kallikreins Human genes 0.000 description 1
• 229960001669 Kinetin Drugs 0.000 description 1
• LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-2-aminohexanoic acid zwitterion Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 description 1
• LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine zwitterion Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
• GGLZPLKKBSSKCX-YFKPBYRVSA-N L-ethionine Chemical compound CCSCC[C@H](N)C(O)=O GGLZPLKKBSSKCX-YFKPBYRVSA-N 0.000 description 1
• QUOGESRFPZDMMT-YFKPBYRVSA-N L-homoarginine Chemical compound OC(=O)[C@@H](N)CCCCNC(N)=N QUOGESRFPZDMMT-YFKPBYRVSA-N 0.000 description 1
• JTTHKOPSMAVJFE-VIFPVBQESA-N L-homophenylalanine Chemical compound OC(=O)[C@@H](N)CCC1=CC=CC=C1 JTTHKOPSMAVJFE-VIFPVBQESA-N 0.000 description 1
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
• AHLPHDHHMVZTML-BYPYZUCNSA-N L-ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
• 125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 description 1
• 102100005410 LINE-1 retrotransposable element ORF2 protein Human genes 0.000 description 1
• 240000005993 Lactuca saligna Species 0.000 description 1
• 235000003228 Lactuca sativa Nutrition 0.000 description 1
• 240000008415 Lactuca sativa Species 0.000 description 1
• 229920001543 Laminarin Polymers 0.000 description 1
• 229940067606 Lecithin Drugs 0.000 description 1
• 208000008456 Leukemia, Myelogenous, Chronic, BCR-ABL Positive Diseases 0.000 description 1
• 208000007046 Leukemia, Myeloid, Acute Diseases 0.000 description 1
• 229960004393 Lidocaine Hydrochloride Drugs 0.000 description 1
• 206010024453 Ligament sprain Diseases 0.000 description 1
• 210000003041 Ligaments Anatomy 0.000 description 1
• 241000234280 Liliaceae Species 0.000 description 1
• 235000004431 Linum usitatissimum Nutrition 0.000 description 1
• 240000006240 Linum usitatissimum Species 0.000 description 1
• XIXADJRWDQXREU-UHFFFAOYSA-M Lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 1
• 229940071257 Lithium acetate Drugs 0.000 description 1
• 210000004072 Lung Anatomy 0.000 description 1
• 208000009856 Lung Disease Diseases 0.000 description 1
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
• 208000010447 Lymphatic Disease Diseases 0.000 description 1
• 208000002502 Lymphedema Diseases 0.000 description 1
• 210000004698 Lymphocytes Anatomy 0.000 description 1
• 206010025282 Lymphoedema Diseases 0.000 description 1
• 241000282564 Macaca fuscata Species 0.000 description 1
• GVALZJMUIHGIMD-UHFFFAOYSA-H Magnesium phosphate tribasic Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
• 208000000200 Male Genital Disease Diseases 0.000 description 1
• 208000007466 Male Infertility Diseases 0.000 description 1
• 206010025650 Malignant melanoma Diseases 0.000 description 1
• 241000220225 Malus Species 0.000 description 1
• 235000005087 Malus prunifolia Nutrition 0.000 description 1
• 240000002593 Malus prunifolia Species 0.000 description 1
• 235000011430 Malus pumila Nutrition 0.000 description 1
• 235000015103 Malus silvestris Nutrition 0.000 description 1
• 206010026817 Maple syrup disease Diseases 0.000 description 1
• 210000000138 Mast Cells Anatomy 0.000 description 1
• 240000004658 Medicago sativa Species 0.000 description 1
• 230000036119 Metabolite Levels Effects 0.000 description 1
• 229960002900 Methylcellulose Drugs 0.000 description 1
• 241001467578 Microbacterium Species 0.000 description 1
• 210000003470 Mitochondria Anatomy 0.000 description 1
• 229920000460 Mitochondrial DNA Polymers 0.000 description 1
• 108020005196 Mitochondrial DNA Proteins 0.000 description 1
• 210000002200 Mouth Mucosa Anatomy 0.000 description 1
• 208000000690 Mucopolysaccharidosis VI Diseases 0.000 description 1
• 241000699670 Mus sp. Species 0.000 description 1
• 210000003205 Muscles Anatomy 0.000 description 1
• 241000204051 Mycoplasma genitalium Species 0.000 description 1
• 229940013390 Mycoplasma pneumoniae Drugs 0.000 description 1
• 241000202934 Mycoplasma pneumoniae Species 0.000 description 1
• 241000202946 Mycoplasma pulmonis Species 0.000 description 1
• 210000004683 Myoblasts, Skeletal Anatomy 0.000 description 1
• 206010028593 Myocardial disease Diseases 0.000 description 1
• 210000004413 Myocytes, Cardiac Anatomy 0.000 description 1
• 210000000329 Myocytes, Smooth Muscle Anatomy 0.000 description 1
• CDAISMWEOUEBRE-UHFFFAOYSA-N Myoinositol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
• 241000588653 Neisseria Species 0.000 description 1
• 229940105631 Nembutal Drugs 0.000 description 1
• 206010058116 Nephrogenic anaemia Diseases 0.000 description 1
• 241001182492 Nes Species 0.000 description 1
• 206010029260 Neuroblastoma Diseases 0.000 description 1
• 206010029331 Neuropathy peripheral Diseases 0.000 description 1
• 210000001331 Nose Anatomy 0.000 description 1
• 229920002248 Nuclear DNA Polymers 0.000 description 1
• 210000000633 Nuclear Envelope Anatomy 0.000 description 1
• 239000004677 Nylon Substances 0.000 description 1
• 208000008589 Obesity Diseases 0.000 description 1
• 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
• 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
• 229960003104 Ornithine Drugs 0.000 description 1
• 208000001132 Osteoporosis Diseases 0.000 description 1
• 206010033128 Ovarian cancer Diseases 0.000 description 1
• 102100013412 PGK2 Human genes 0.000 description 1
• 102100012348 POLD1 Human genes 0.000 description 1
• 102100019167 POLH Human genes 0.000 description 1
• 101700036698 POLH Proteins 0.000 description 1
• 102100012460 POLM Human genes 0.000 description 1
• 101710039566 POLQ Proteins 0.000 description 1
• 102100012458 POLQ Human genes 0.000 description 1
• 241000282579 Pan Species 0.000 description 1
• 241000282577 Pan troglodytes Species 0.000 description 1
• 210000000496 Pancreas Anatomy 0.000 description 1
• 208000008443 Pancreatic Carcinoma Diseases 0.000 description 1
• 210000000277 Pancreatic Ducts Anatomy 0.000 description 1
• 206010033616 Pancreatic disease Diseases 0.000 description 1
• 206010033647 Pancreatitis acute Diseases 0.000 description 1
• 206010033649 Pancreatitis chronic Diseases 0.000 description 1
• 208000003278 Patent Ductus Arteriosus Diseases 0.000 description 1
• WEXRUCMBJFQVBZ-UHFFFAOYSA-N Pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 1
• 229960001412 Pentobarbital Drugs 0.000 description 1
• 239000006002 Pepper Substances 0.000 description 1
• 108010043958 Peptoids Proteins 0.000 description 1
• 239000001888 Peptone Substances 0.000 description 1
• 108010080698 Peptones Proteins 0.000 description 1
• 206010034468 Pericardial disease Diseases 0.000 description 1
• WRMNZCZEMHIOCP-UHFFFAOYSA-N Phenethyl alcohol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 1
• 235000016761 Piper aduncum Nutrition 0.000 description 1
• 235000017804 Piper guineense Nutrition 0.000 description 1
• 240000000129 Piper nigrum Species 0.000 description 1
• 235000008184 Piper nigrum Nutrition 0.000 description 1
• 208000002744 Pituitary Disease Diseases 0.000 description 1
• 210000002826 Placenta Anatomy 0.000 description 1
• 206010035664 Pneumonia Diseases 0.000 description 1
• 231100000614 Poison Toxicity 0.000 description 1
• 206010061529 Polyp Diseases 0.000 description 1
• 229920001213 Polysorbate 20 Polymers 0.000 description 1
• 229920001214 Polysorbate 60 Polymers 0.000 description 1
• 239000004372 Polyvinyl alcohol Substances 0.000 description 1
• 241000219000 Populus Species 0.000 description 1
• 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
• HCBIBCJNVBAKAB-UHFFFAOYSA-N Procaine hydrochloride Chemical compound Cl.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 HCBIBCJNVBAKAB-UHFFFAOYSA-N 0.000 description 1
• 229960001309 Procaine hydrochloride Drugs 0.000 description 1
• 210000002307 Prostate Anatomy 0.000 description 1
• 206010060862 Prostate cancer Diseases 0.000 description 1
• 235000015533 Prunus davidiana Nutrition 0.000 description 1
• 240000002381 Prunus davidiana Species 0.000 description 1
• 235000006040 Prunus persica var persica Nutrition 0.000 description 1
• 241000589516 Pseudomonas Species 0.000 description 1
• 229940055023 Pseudomonas aeruginosa Drugs 0.000 description 1
• 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
• 229960004172 Pyridoxine Hydrochloride Drugs 0.000 description 1
• XPPKVPWEQAFLFU-UHFFFAOYSA-J Pyrophosphate Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
• 229940048084 Pyrophosphate Drugs 0.000 description 1
• 229940076788 Pyruvate Drugs 0.000 description 1
• 108020004511 Recombinant DNA Proteins 0.000 description 1
• 206010038038 Rectal cancer Diseases 0.000 description 1
• 208000009527 Refractory Anemia Diseases 0.000 description 1
• 206010072684 Refractory cytopenia with unilineage dysplasia Diseases 0.000 description 1
• 206010038389 Renal cancer Diseases 0.000 description 1
• 206010038435 Renal failure Diseases 0.000 description 1
• 206010038545 Renal vascular disorder Diseases 0.000 description 1
• 210000001525 Retina Anatomy 0.000 description 1
• 206010038997 Retroviral infection Diseases 0.000 description 1
• 102000002278 Ribosomal Proteins Human genes 0.000 description 1
• 108010000605 Ribosomal Proteins Proteins 0.000 description 1
• 241000220317 Rosa Species 0.000 description 1
• 235000004789 Rosa xanthina Nutrition 0.000 description 1
• 241000220222 Rosaceae Species 0.000 description 1
• 241000607142 Salmonella Species 0.000 description 1
• 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
• 206010039447 Salmonellosis Diseases 0.000 description 1
• 206010039491 Sarcoma Diseases 0.000 description 1
• 241000607720 Serratia Species 0.000 description 1
• 229920001800 Shellac Polymers 0.000 description 1
• 241001518905 Shigella flexneri 2a str. 301 Species 0.000 description 1
• 108020004682 Single-Stranded DNA Proteins 0.000 description 1
• 206010054184 Small intestine carcinoma Diseases 0.000 description 1
• 229940005550 Sodium alginate Drugs 0.000 description 1
• 241000208292 Solanaceae Species 0.000 description 1
• 235000002595 Solanum tuberosum Nutrition 0.000 description 1
• 240000001016 Solanum tuberosum Species 0.000 description 1
• 229940075582 Sorbic Acid Drugs 0.000 description 1
• 208000008513 Spinal Cord Injury Diseases 0.000 description 1
• 241000295644 Staphylococcaceae Species 0.000 description 1
• 229940076185 Staphylococcus aureus Drugs 0.000 description 1
• 241000191967 Staphylococcus aureus Species 0.000 description 1
• 235000021355 Stearic acid Nutrition 0.000 description 1
• DCXXMTOCNZCJGO-UHFFFAOYSA-N Stearin Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
• 208000001492 Stomach Disease Diseases 0.000 description 1
• 241000187432 Streptomyces coelicolor Species 0.000 description 1
• 208000006011 Stroke Diseases 0.000 description 1
• 241000282887 Suidae Species 0.000 description 1
• 201000001322 T cell deficiency Diseases 0.000 description 1
• 210000001744 T-Lymphocytes Anatomy 0.000 description 1
• 241001441723 Takifugu Species 0.000 description 1
• 108010006785 Taq Polymerase Proteins 0.000 description 1
• 241000255588 Tephritidae Species 0.000 description 1
• 206010057644 Testis cancer Diseases 0.000 description 1
• 229960002180 Tetracycline Drugs 0.000 description 1
• OFVLGDICTFRJMM-WESIUVDSSA-N Tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 description 1
• 239000004098 Tetracycline Substances 0.000 description 1
• FQENQNTWSFEDLI-UHFFFAOYSA-J Tetrasodium pyrophosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
• 229960000344 Thiamine hydrochloride Drugs 0.000 description 1
• 206010043554 Thrombocytopenia Diseases 0.000 description 1
• 102000006601 Thymidine Kinase Human genes 0.000 description 1
• 108020004440 Thymidine Kinase Proteins 0.000 description 1
• 206010043709 Thyroid disease Diseases 0.000 description 1
• 241000723873 Tobacco mosaic virus Species 0.000 description 1
• GSEJCLTVZPLZKY-UHFFFAOYSA-N Tris Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
• 239000007983 Tris buffer Substances 0.000 description 1
• HWKQNAWCHQMZHK-UHFFFAOYSA-N Trolnitrate Chemical compound [O-][N+](=O)OCCN(CCO[N+]([O-])=O)CCO[N+]([O-])=O HWKQNAWCHQMZHK-UHFFFAOYSA-N 0.000 description 1
• 210000003954 Umbilical Cord Anatomy 0.000 description 1
• 229910052770 Uranium Inorganic materials 0.000 description 1
• 208000005918 Urinary Bladder Disease Diseases 0.000 description 1
• 206010046766 Uterine cancer Diseases 0.000 description 1
• 206010046798 Uterine leiomyoma Diseases 0.000 description 1
• 206010046996 Varicose vein Diseases 0.000 description 1
• 208000001910 Ventricular Heart Septal Defects Diseases 0.000 description 1
• 229940118696 Vibrio cholerae Drugs 0.000 description 1
• 241000607626 Vibrio cholerae Species 0.000 description 1
• 229940088594 Vitamin Drugs 0.000 description 1
• 241000282485 Vulpes vulpes Species 0.000 description 1
• 108060009497 WRNexo Proteins 0.000 description 1
• 206010053687 Wolman's disease Diseases 0.000 description 1
• 210000004340 Zona Pellucida Anatomy 0.000 description 1
• KDWJSKVQQPOWRR-UGDNZRGBSA-N [(2S,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl dihydrogen phosphate Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(COP(O)(O)=O)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 KDWJSKVQQPOWRR-UGDNZRGBSA-N 0.000 description 1
• 230000001133 acceleration Effects 0.000 description 1
• QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
• 239000008351 acetate buffer Substances 0.000 description 1
• DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
• 230000002378 acidificating Effects 0.000 description 1
• 230000004913 activation Effects 0.000 description 1
• 201000005510 acute lymphocytic leukemia Diseases 0.000 description 1
• 201000003229 acute pancreatitis Diseases 0.000 description 1
• 238000005917 acylation reaction Methods 0.000 description 1
• 210000001789 adipocyte Anatomy 0.000 description 1
• 230000001058 adult Effects 0.000 description 1
• 238000005273 aeration Methods 0.000 description 1
• 238000009632 agar plate Methods 0.000 description 1
• 230000001476 alcoholic Effects 0.000 description 1
• 235000017585 alfalfa Nutrition 0.000 description 1
• 235000017587 alfalfa Nutrition 0.000 description 1
• 239000003513 alkali Substances 0.000 description 1
• 150000003797 alkaloid derivatives Chemical class 0.000 description 1
• 229930013930 alkaloids Natural products 0.000 description 1
• 238000005804 alkylation reaction Methods 0.000 description 1
• 229930002945 all-trans-retinaldehyde Natural products 0.000 description 1
• 201000004384 alopecia Diseases 0.000 description 1
• 231100000360 alopecia Toxicity 0.000 description 1
• 102000005840 alpha-Galactosidase Human genes 0.000 description 1
• 108010030291 alpha-Galactosidase Proteins 0.000 description 1
• 229920002892 amber Polymers 0.000 description 1
• 238000007112 amidation reaction Methods 0.000 description 1
• 150000003862 amino acid derivatives Chemical class 0.000 description 1
• QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
• USFZMSVCRYTOJT-UHFFFAOYSA-N ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
• 235000019257 ammonium acetate Nutrition 0.000 description 1
• 229940043376 ammonium acetate Drugs 0.000 description 1
• 235000019270 ammonium chloride Nutrition 0.000 description 1
• 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
• 235000019289 ammonium phosphates Nutrition 0.000 description 1
• 150000003863 ammonium salts Chemical class 0.000 description 1
• 230000003698 anagen phase Effects 0.000 description 1
• 201000003076 angiosarcoma Diseases 0.000 description 1
• 230000000845 anti-microbial Effects 0.000 description 1
• 229960000070 antineoplastic Monoclonal antibodies Drugs 0.000 description 1
• 230000003078 antioxidant Effects 0.000 description 1
• KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 1
• 200000000007 arterial disease Diseases 0.000 description 1
• 230000011681 asexual reproduction Effects 0.000 description 1
• 235000006705 asparagus lettuce Nutrition 0.000 description 1
• 239000002363 auxin Substances 0.000 description 1
• 239000003899 bactericide agent Substances 0.000 description 1
• 230000006399 behavior Effects 0.000 description 1
• 230000003542 behavioural Effects 0.000 description 1
• 239000000440 bentonite Substances 0.000 description 1
• 229910000278 bentonite Inorganic materials 0.000 description 1
• 229960004217 benzyl alcohol Drugs 0.000 description 1
• 229960002903 benzyl benzoate Drugs 0.000 description 1
• 230000002457 bidirectional Effects 0.000 description 1
• 201000004532 bilirubin metabolic disease Diseases 0.000 description 1
• 230000035514 bioavailability Effects 0.000 description 1
• 238000002306 biochemical method Methods 0.000 description 1
• 238000010876 biochemical test Methods 0.000 description 1
• 230000005540 biological transmission Effects 0.000 description 1
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
• 229960002685 biotin Drugs 0.000 description 1
• 235000020958 biotin Nutrition 0.000 description 1
• 239000011616 biotin Substances 0.000 description 1
• LSNNMFCWUKXFEE-UHFFFAOYSA-M bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
• 201000008848 bladder disease Diseases 0.000 description 1
• 230000000903 blocking Effects 0.000 description 1
• 230000037396 body weight Effects 0.000 description 1
• 238000006664 bond formation reaction Methods 0.000 description 1
• 210000002449 bone cell Anatomy 0.000 description 1
• 239000004327 boric acid Substances 0.000 description 1
• 235000010338 boric acid Nutrition 0.000 description 1
• 239000007975 buffered saline Substances 0.000 description 1
• 239000004067 bulking agent Substances 0.000 description 1
• 238000010804 cDNA synthesis Methods 0.000 description 1
• UXVMQQNJUSDDNG-UHFFFAOYSA-L cacl2 Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
• BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
• 229910052793 cadmium Inorganic materials 0.000 description 1
• 235000012970 cakes Nutrition 0.000 description 1
• 239000001110 calcium chloride Substances 0.000 description 1
• 229910001628 calcium chloride Inorganic materials 0.000 description 1
• 235000013539 calcium stearate Nutrition 0.000 description 1
• 239000008116 calcium stearate Substances 0.000 description 1
• 235000013877 carbamide Nutrition 0.000 description 1
• CURLTUGMZLYLDI-UHFFFAOYSA-N carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
• 239000001569 carbon dioxide Substances 0.000 description 1
• 229910002092 carbon dioxide Inorganic materials 0.000 description 1
• UGFAIRIUMAVXCW-UHFFFAOYSA-N carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
• 229910002091 carbon monoxide Inorganic materials 0.000 description 1
• 238000006473 carboxylation reaction Methods 0.000 description 1
• 210000002317 cardiac myocyte Anatomy 0.000 description 1
• 239000005018 casein Substances 0.000 description 1
• 235000021240 caseins Nutrition 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 230000003197 catalytic Effects 0.000 description 1
• 239000003729 cation exchange resin Substances 0.000 description 1
• 125000002091 cationic group Chemical group 0.000 description 1
• 239000006285 cell suspension Substances 0.000 description 1
• 230000001413 cellular Effects 0.000 description 1
• 230000036755 cellular response Effects 0.000 description 1
• 238000005119 centrifugation Methods 0.000 description 1
• 239000002738 chelating agent Substances 0.000 description 1
• 238000007385 chemical modification Methods 0.000 description 1
• 230000000973 chemotherapeutic Effects 0.000 description 1
• 235000012000 cholesterol Nutrition 0.000 description 1
• 230000002759 chromosomal Effects 0.000 description 1
• 230000001684 chronic Effects 0.000 description 1
• 201000006934 chronic myeloid leukemia Diseases 0.000 description 1
• 210000000079 cloven hoof Anatomy 0.000 description 1
• 238000003501 co-culture Methods 0.000 description 1
• 229940110456 cocoa butter Drugs 0.000 description 1
• 235000019868 cocoa butter Nutrition 0.000 description 1
• 238000004040 coloring Methods 0.000 description 1
• 230000000052 comparative effect Effects 0.000 description 1
• 239000002131 composite material Substances 0.000 description 1
• 238000004590 computer program Methods 0.000 description 1
• 201000003137 congenital heart disease Diseases 0.000 description 1
• 230000021615 conjugation Effects 0.000 description 1
• 239000000599 controlled substance Substances 0.000 description 1
• 229910000365 copper sulfate Inorganic materials 0.000 description 1
• 239000002285 corn oil Substances 0.000 description 1
• 235000005687 corn oil Nutrition 0.000 description 1
• 239000002537 cosmetic Substances 0.000 description 1
• 238000004132 cross linking Methods 0.000 description 1
• 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
• 239000012228 culture supernatant Substances 0.000 description 1
• 238000005520 cutting process Methods 0.000 description 1
• 125000004122 cyclic group Chemical group 0.000 description 1
• 150000001945 cysteines Chemical class 0.000 description 1
• 201000003146 cystitis Diseases 0.000 description 1
• 239000004062 cytokinin Substances 0.000 description 1
• 230000000254 damaging Effects 0.000 description 1
• 229940061632 dehydroacetic acid Drugs 0.000 description 1
• 235000019258 dehydroacetic acid Nutrition 0.000 description 1
• 239000003398 denaturant Substances 0.000 description 1
• 239000005549 deoxyribonucleoside Substances 0.000 description 1
• 230000027832 depurination Effects 0.000 description 1
• 231100000406 dermatitis Toxicity 0.000 description 1
• 230000001066 destructive Effects 0.000 description 1
• 230000001627 detrimental Effects 0.000 description 1
• 229960002086 dextran Drugs 0.000 description 1
• 201000010064 diabetes insipidus Diseases 0.000 description 1
• 239000000032 diagnostic agent Substances 0.000 description 1
• MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
• 201000008849 diaphragm disease Diseases 0.000 description 1
• 230000001079 digestive Effects 0.000 description 1
• 238000007865 diluting Methods 0.000 description 1
• 238000010790 dilution Methods 0.000 description 1
• 235000011180 diphosphates Nutrition 0.000 description 1
• 210000001840 diploid cell Anatomy 0.000 description 1
• 235000019797 dipotassium phosphate Nutrition 0.000 description 1
• 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
• 150000002016 disaccharides Chemical class 0.000 description 1
• 201000009910 diseases by infectious agent Diseases 0.000 description 1
• 238000006073 displacement reaction Methods 0.000 description 1
• 108060002323 dnaE Proteins 0.000 description 1
• 239000002552 dosage form Substances 0.000 description 1
• 239000008298 dragée Substances 0.000 description 1
• 230000000857 drug effect Effects 0.000 description 1
• 230000036267 drug metabolism Effects 0.000 description 1
• 238000003255 drug test Methods 0.000 description 1
• 241001493065 dsRNA viruses Species 0.000 description 1
• 201000000312 duodenum cancer Diseases 0.000 description 1
• 230000004064 dysfunction Effects 0.000 description 1
• 231100001003 eczema Toxicity 0.000 description 1
• 239000003995 emulsifying agent Substances 0.000 description 1
• 210000000750 endocrine system Anatomy 0.000 description 1
• 201000009273 endometriosis Diseases 0.000 description 1
• 201000009274 endometriosis of uterus Diseases 0.000 description 1
• 239000002662 enteric coated tablet Substances 0.000 description 1
• 230000002255 enzymatic Effects 0.000 description 1
• 210000002514 epidermal stem cell Anatomy 0.000 description 1
• 201000004101 esophageal cancer Diseases 0.000 description 1
• 230000003203 everyday Effects 0.000 description 1
• 229960001781 ferrous sulfate Drugs 0.000 description 1
• 239000011790 ferrous sulphate Substances 0.000 description 1
• 235000003891 ferrous sulphate Nutrition 0.000 description 1
• 230000004720 fertilization Effects 0.000 description 1
• 239000000835 fiber Substances 0.000 description 1
• 239000000945 filler Substances 0.000 description 1
• 239000007941 film coated tablet Substances 0.000 description 1
• 238000001914 filtration Methods 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• 125000005519 fluorenylmethyloxycarbonyl group Chemical group 0.000 description 1
• 235000013355 food flavoring agent Nutrition 0.000 description 1
• 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
• 238000004108 freeze drying Methods 0.000 description 1
• 125000000524 functional group Chemical group 0.000 description 1
• 230000004927 fusion Effects 0.000 description 1
• 230000002496 gastric Effects 0.000 description 1
• 230000004545 gene duplication Effects 0.000 description 1
• 238000010360 gene modification Methods 0.000 description 1
• 238000007429 general method Methods 0.000 description 1
• 238000010358 genetic engineering technique Methods 0.000 description 1
• 235000003869 genetically modified organisms (GMOs) Nutrition 0.000 description 1
• 231100000852 glomerular disease Toxicity 0.000 description 1
• 230000004153 glucose metabolism Effects 0.000 description 1
• 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
• 150000004676 glycans Polymers 0.000 description 1
• 125000005456 glyceride group Chemical group 0.000 description 1
• 229940075507 glyceryl monostearate Drugs 0.000 description 1
• LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
• 229910052737 gold Inorganic materials 0.000 description 1
• 239000010931 gold Substances 0.000 description 1
• 239000002622 gonadotropin Substances 0.000 description 1
• 239000008187 granular material Substances 0.000 description 1
• 230000026781 habituation Effects 0.000 description 1
• 230000003394 haemopoietic Effects 0.000 description 1
• 238000005658 halogenation reaction Methods 0.000 description 1
• 210000003783 haploid cell Anatomy 0.000 description 1
• 239000007902 hard capsule Substances 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 201000010238 heart disease Diseases 0.000 description 1
• 210000003897 hepatic stem cell Anatomy 0.000 description 1
• 201000008298 histiocytosis Diseases 0.000 description 1
• 230000002962 histologic Effects 0.000 description 1
• 230000003284 homeostatic Effects 0.000 description 1
• 230000013632 homeostatic process Effects 0.000 description 1
• 235000003642 hunger Nutrition 0.000 description 1
• 229960002773 hyaluronidase Drugs 0.000 description 1
• UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
• 239000000413 hydrolysate Substances 0.000 description 1
• 238000006460 hydrolysis reaction Methods 0.000 description 1
• 230000003301 hydrolyzing Effects 0.000 description 1
• 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
• 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
• 230000000640 hydroxylating Effects 0.000 description 1
• 238000005805 hydroxylation reaction Methods 0.000 description 1
• 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
• 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
• 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
• 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
• 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 description 1
• 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 description 1
• 230000003100 immobilizing Effects 0.000 description 1
• 230000028993 immune response Effects 0.000 description 1
• 238000001114 immunoprecipitation Methods 0.000 description 1
• 230000001976 improved Effects 0.000 description 1
• 238000000126 in silico method Methods 0.000 description 1
• 238000007901 in situ hybridization Methods 0.000 description 1
• 230000000415 inactivating Effects 0.000 description 1
• SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 1
• 239000000411 inducer Substances 0.000 description 1
• 238000001802 infusion Methods 0.000 description 1
• 239000004615 ingredient Substances 0.000 description 1
• 230000002452 interceptive Effects 0.000 description 1
• 238000010255 intramuscular injection Methods 0.000 description 1
• 239000007927 intramuscular injection Substances 0.000 description 1
• 238000007912 intraperitoneal administration Methods 0.000 description 1
• 238000007913 intrathecal administration Methods 0.000 description 1
• 238000010253 intravenous injection Methods 0.000 description 1
• 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
• 230000001788 irregular Effects 0.000 description 1
• BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl β-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
• 239000007951 isotonicity adjuster Substances 0.000 description 1
• 201000010982 kidney cancer Diseases 0.000 description 1
• 238000002372 labelling Methods 0.000 description 1
• 150000002611 lead compounds Chemical class 0.000 description 1
• 235000010445 lecithin Nutrition 0.000 description 1
• 239000000787 lecithin Substances 0.000 description 1
• 235000021374 legumes Nutrition 0.000 description 1
• 231100000636 lethal dose Toxicity 0.000 description 1
• YECIFGHRMFEPJK-UHFFFAOYSA-N lidocaine hydrochloride monohydrate Chemical compound O.[Cl-].CC[NH+](CC)CC(=O)NC1=C(C)C=CC=C1C YECIFGHRMFEPJK-UHFFFAOYSA-N 0.000 description 1
• 230000000670 limiting Effects 0.000 description 1
• 230000037356 lipid metabolism Effects 0.000 description 1
• 238000001638 lipofection Methods 0.000 description 1
• 238000009630 liquid culture Methods 0.000 description 1
• 201000007270 liver cancer Diseases 0.000 description 1
• 201000004044 liver cirrhosis Diseases 0.000 description 1
• 201000005202 lung cancer Diseases 0.000 description 1
• 201000002135 lymphatic system disease Diseases 0.000 description 1
• 229960003511 macrogol Drugs 0.000 description 1
• 239000011777 magnesium Substances 0.000 description 1
• 239000004137 magnesium phosphate Substances 0.000 description 1
• 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
• 229960002261 magnesium phosphate Drugs 0.000 description 1
• 235000010994 magnesium phosphates Nutrition 0.000 description 1
• 235000019359 magnesium stearate Nutrition 0.000 description 1
• 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
• 229960003390 magnesium sulfate Drugs 0.000 description 1
• 235000019341 magnesium sulphate Nutrition 0.000 description 1
• 230000014759 maintenance of location Effects 0.000 description 1
• 210000003794 male germ cell Anatomy 0.000 description 1
• 229940099596 manganese sulfate Drugs 0.000 description 1
• 239000011702 manganese sulphate Substances 0.000 description 1
• 235000007079 manganese sulphate Nutrition 0.000 description 1
• ISPYRSDWRDQNSW-UHFFFAOYSA-L manganese(II) sulfate monohydrate Chemical compound O.[Mn+2].[O-]S([O-])(=O)=O ISPYRSDWRDQNSW-UHFFFAOYSA-L 0.000 description 1
• 239000000594 mannitol Substances 0.000 description 1
• 201000011221 maple syrup urine disease Diseases 0.000 description 1
• 239000003550 marker Substances 0.000 description 1
• 201000001441 melanoma Diseases 0.000 description 1
• 201000009906 meningitis Diseases 0.000 description 1
• QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
• 229910052753 mercury Inorganic materials 0.000 description 1
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
• 230000002906 microbiologic Effects 0.000 description 1
• 239000003094 microcapsule Substances 0.000 description 1
• 238000000520 microinjection Methods 0.000 description 1
• 239000011859 microparticle Substances 0.000 description 1
• 230000003278 mimic Effects 0.000 description 1
• 230000002438 mitochondrial Effects 0.000 description 1
• 239000011259 mixed solution Substances 0.000 description 1
• 238000002715 modification method Methods 0.000 description 1
• 235000013379 molasses Nutrition 0.000 description 1
• 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
• QDHHCQZDFGDHMP-UHFFFAOYSA-N monochloramine Chemical compound ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 description 1
• 229960000060 monoclonal antibodies Drugs 0.000 description 1
• 230000004899 motility Effects 0.000 description 1
• 238000010172 mouse model Methods 0.000 description 1
• 210000004877 mucosa Anatomy 0.000 description 1
• 238000003541 multi-stage reaction Methods 0.000 description 1
• 201000009251 multiple myeloma Diseases 0.000 description 1
• 210000000663 muscle cells Anatomy 0.000 description 1
• 210000002346 musculoskeletal system Anatomy 0.000 description 1
• 239000006199 nebulizer Substances 0.000 description 1
• 210000003757 neuroblast Anatomy 0.000 description 1
• 201000001119 neuropathy Diseases 0.000 description 1
• 235000001968 nicotinic acid Nutrition 0.000 description 1
• 229960003512 nicotinic acid Drugs 0.000 description 1
• 239000011664 nicotinic acid Substances 0.000 description 1
• QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
• 230000003000 nontoxic Effects 0.000 description 1
• 231100000252 nontoxic Toxicity 0.000 description 1
• 229920001778 nylon Polymers 0.000 description 1
• CTQNGGLPUBDAKN-UHFFFAOYSA-N o-xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
• 235000020824 obesity Nutrition 0.000 description 1
• 239000002751 oligonucleotide probe Substances 0.000 description 1
• 229920001542 oligosaccharide Polymers 0.000 description 1
• 150000002482 oligosaccharides Polymers 0.000 description 1
• 230000011164 ossification Effects 0.000 description 1
• 201000008482 osteoarthritis Diseases 0.000 description 1
• 210000000963 osteoblast Anatomy 0.000 description 1
• 230000000790 osteoblast Effects 0.000 description 1
• 201000008968 osteosarcoma Diseases 0.000 description 1
• 201000005617 ovarian disease Diseases 0.000 description 1
• 201000004535 ovarian dysfunction Diseases 0.000 description 1
• 231100000543 ovarian dysfunction Toxicity 0.000 description 1
• 230000001590 oxidative Effects 0.000 description 1
• 239000001301 oxygen Substances 0.000 description 1
• 229910052760 oxygen Inorganic materials 0.000 description 1
• MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
• 201000002528 pancreatic cancer Diseases 0.000 description 1
• 210000004738 parenchymal cell Anatomy 0.000 description 1
• 230000008506 pathogenesis Effects 0.000 description 1
• 239000000816 peptidomimetic Substances 0.000 description 1
• 235000019319 peptone Nutrition 0.000 description 1
• 230000035699 permeability Effects 0.000 description 1
• 239000000546 pharmaceutic aid Substances 0.000 description 1
• 230000002974 pharmacogenomic Effects 0.000 description 1
• 201000011252 phenylketonuria Diseases 0.000 description 1
• 239000008363 phosphate buffer Substances 0.000 description 1
• PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 1
• 230000000704 physical effect Effects 0.000 description 1
• 230000001766 physiological effect Effects 0.000 description 1
• 230000035479 physiological effects, processes and functions Effects 0.000 description 1
• 239000002504 physiological saline solution Substances 0.000 description 1
• 210000004694 pigment cell Anatomy 0.000 description 1
• 201000002056 pituitary gland disease Diseases 0.000 description 1
• 239000005648 plant growth regulator Substances 0.000 description 1
• 210000001778 pluripotent stem cell Anatomy 0.000 description 1
• 239000002574 poison Substances 0.000 description 1
• 101700040843 pol1 Proteins 0.000 description 1
• 108060002324 polC Proteins 0.000 description 1
• 229920002401 polyacrylamide Polymers 0.000 description 1
• 108091008117 polyclonal antibodies Proteins 0.000 description 1
• 230000000379 polymerizing Effects 0.000 description 1
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
• 229920001282 polysaccharide Polymers 0.000 description 1
• 239000005017 polysaccharide Substances 0.000 description 1
• 150000004804 polysaccharides Polymers 0.000 description 1
• 229920000136 polysorbate Polymers 0.000 description 1
• 229920002451 polyvinyl alcohol Polymers 0.000 description 1
• 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
• WCUXLLCKKVVCTQ-UHFFFAOYSA-M potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 1
• 229910000160 potassium phosphate Inorganic materials 0.000 description 1
• OFPTZWGZSRJCOT-MSPNRCMCSA-M potassium;2-[(1S,2S,3R,4S,5S,6R)-3-(diaminomethylideneamino)-4-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine;(2S,5R,6R)-3,3-d Chemical compound [K+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@H]1[C@H](N=C(N)N)[C@@H](O)[C@H](N=C(N)N)[C@@H](O)[C@@H]1O OFPTZWGZSRJCOT-MSPNRCMCSA-M 0.000 description 1
• 239000002244 precipitate Substances 0.000 description 1
• OZAIFHULBGXAKX-UHFFFAOYSA-N precursor Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 1
• 230000001737 promoting Effects 0.000 description 1
• 230000000644 propagated Effects 0.000 description 1
• 235000019260 propionic acid Nutrition 0.000 description 1
• 238000003498 protein array Methods 0.000 description 1
• 238000000159 protein binding assay Methods 0.000 description 1
• 230000022558 protein metabolic process Effects 0.000 description 1
• 230000037150 protein metabolism Effects 0.000 description 1
• 238000001742 protein purification Methods 0.000 description 1
• 230000002685 pulmonary Effects 0.000 description 1
• 150000003212 purines Chemical class 0.000 description 1
• ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
• 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
• 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
• 150000003230 pyrimidines Chemical class 0.000 description 1
• 239000002510 pyrogen Substances 0.000 description 1
• LCTONWCANYUPML-UHFFFAOYSA-M pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
• 238000011002 quantification Methods 0.000 description 1
• 238000004445 quantitative analysis Methods 0.000 description 1
• SMWDFEZZVXVKRB-UHFFFAOYSA-N quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 1
• VBICKXHEKHSIBG-UHFFFAOYSA-N rac-1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
• 230000036647 reaction Effects 0.000 description 1
• 239000011535 reaction buffer Substances 0.000 description 1
• 230000000384 rearing Effects 0.000 description 1
• 201000001275 rectum cancer Diseases 0.000 description 1
• 230000008929 regeneration Effects 0.000 description 1
• 238000011069 regeneration method Methods 0.000 description 1
• 108010051490 replication initiator protein Proteins 0.000 description 1
• 230000001850 reproductive Effects 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 210000002345 respiratory system Anatomy 0.000 description 1
• 230000004044 response Effects 0.000 description 1
• 230000004043 responsiveness Effects 0.000 description 1
• 230000000284 resting Effects 0.000 description 1
• 230000000717 retained Effects 0.000 description 1
• 230000002207 retinal Effects 0.000 description 1
• 235000020945 retinal Nutrition 0.000 description 1
• 239000011604 retinal Substances 0.000 description 1
• 230000001177 retroviral Effects 0.000 description 1
• 230000002441 reversible Effects 0.000 description 1
• 230000002987 rna-interference Effects 0.000 description 1
• 101710038532 rpl44e Proteins 0.000 description 1
• 235000019515 salmon Nutrition 0.000 description 1
• 230000028327 secretion Effects 0.000 description 1
• 238000010187 selection method Methods 0.000 description 1
• 230000035945 sensitivity Effects 0.000 description 1
• 239000008159 sesame oil Substances 0.000 description 1
• 235000011803 sesame oil Nutrition 0.000 description 1
• 230000014639 sexual reproduction Effects 0.000 description 1
• 239000004208 shellac Substances 0.000 description 1
• 235000013874 shellac Nutrition 0.000 description 1
• 229940113147 shellac Drugs 0.000 description 1
• 230000035939 shock Effects 0.000 description 1
• 230000019491 signal transduction Effects 0.000 description 1
• 230000011664 signaling Effects 0.000 description 1
• 229910052709 silver Inorganic materials 0.000 description 1
• 239000004332 silver Substances 0.000 description 1
• BQCADISMDOOEFD-UHFFFAOYSA-N silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
• 238000004088 simulation Methods 0.000 description 1
• 210000002363 skeletal muscle cell Anatomy 0.000 description 1
• 210000000813 small intestine Anatomy 0.000 description 1
• 239000003998 snake venom Substances 0.000 description 1
• MSXHSNHNTORCAW-UHFFFAOYSA-M sodium 3,4,5,6-tetrahydroxyoxane-2-carboxylate Chemical compound [Na+].OC1OC(C([O-])=O)C(O)C(O)C1O MSXHSNHNTORCAW-UHFFFAOYSA-M 0.000 description 1
• 235000010413 sodium alginate Nutrition 0.000 description 1
• 239000000661 sodium alginate Substances 0.000 description 1
• 235000017557 sodium bicarbonate Nutrition 0.000 description 1
• 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
• 239000001187 sodium carbonate Substances 0.000 description 1
• 229910000029 sodium carbonate Inorganic materials 0.000 description 1
• 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
• 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
• 235000011121 sodium hydroxide Nutrition 0.000 description 1
• 229940048086 sodium pyrophosphate Drugs 0.000 description 1
• 239000007901 soft capsule Substances 0.000 description 1
• 239000011537 solubilization buffer Substances 0.000 description 1
• 230000000392 somatic Effects 0.000 description 1
• 210000001988 somatic stem cell Anatomy 0.000 description 1
• 239000004334 sorbic acid Substances 0.000 description 1
• WSWCOQWTEOXDQX-UHFFFAOYSA-N sorbic acid Chemical compound CC=CC=CC(O)=O WSWCOQWTEOXDQX-UHFFFAOYSA-N 0.000 description 1
• 235000010199 sorbic acid Nutrition 0.000 description 1
• 239000000600 sorbitol Substances 0.000 description 1
• 231100000527 sperm abnormality Toxicity 0.000 description 1
• 108010068698 spleen exonuclease Proteins 0.000 description 1
• 230000002269 spontaneous Effects 0.000 description 1
• 239000007921 spray Substances 0.000 description 1
• 239000008117 stearic acid Substances 0.000 description 1
• 239000008223 sterile water Substances 0.000 description 1
• 150000003431 steroids Chemical class 0.000 description 1
• 238000003756 stirring Methods 0.000 description 1
• 201000011549 stomach cancer Diseases 0.000 description 1
• 239000007940 sugar coated tablet Substances 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 238000005670 sulfation reaction Methods 0.000 description 1
• 239000006228 supernatant Substances 0.000 description 1
• 238000004114 suspension culture Methods 0.000 description 1
• 238000006491 synthase reaction Methods 0.000 description 1
• 239000006188 syrup Substances 0.000 description 1
• 235000020357 syrup Nutrition 0.000 description 1
• 239000000454 talc Substances 0.000 description 1
• 229910052623 talc Inorganic materials 0.000 description 1
• 201000003120 testicular cancer Diseases 0.000 description 1
• 108010008054 testis specific phosphoglycerate kinase Proteins 0.000 description 1
• 235000019364 tetracycline Nutrition 0.000 description 1
• 201000003005 tetralogy of Fallot Diseases 0.000 description 1
• 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
• 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
• DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
• 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
• 239000011747 thiamine hydrochloride Substances 0.000 description 1
• RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
• 230000000699 topical Effects 0.000 description 1
• 230000002588 toxic Effects 0.000 description 1
• 231100000331 toxic Toxicity 0.000 description 1
• 235000021404 traditional food Nutrition 0.000 description 1
• 230000001702 transmitter Effects 0.000 description 1
• 238000002054 transplantation Methods 0.000 description 1
• 239000001226 triphosphate Substances 0.000 description 1
• 235000019798 tripotassium phosphate Nutrition 0.000 description 1
• 210000004881 tumor cells Anatomy 0.000 description 1
• 238000010396 two-hybrid screening Methods 0.000 description 1
• 241000701447 unidentified baculovirus Species 0.000 description 1
• 241001515965 unidentified phage Species 0.000 description 1
• 241001478887 unidentified soil bacteria Species 0.000 description 1
• JFALSRSLKYAFGM-UHFFFAOYSA-N uranium(0) Chemical compound [U] JFALSRSLKYAFGM-UHFFFAOYSA-N 0.000 description 1
• 230000002485 urinary Effects 0.000 description 1
• 201000005112 urinary bladder cancer Diseases 0.000 description 1
• 244000045561 useful plants Species 0.000 description 1
• 229960003726 vasopressin Drugs 0.000 description 1
• 201000003130 ventricular septal defect Diseases 0.000 description 1
• 239000000273 veterinary drug Substances 0.000 description 1
• 230000003612 virological Effects 0.000 description 1
• 230000000007 visual effect Effects 0.000 description 1
• 238000011179 visual inspection Methods 0.000 description 1
• 235000013343 vitamin Nutrition 0.000 description 1
• 239000011782 vitamin Substances 0.000 description 1
• 150000003722 vitamin derivatives Chemical class 0.000 description 1
• 229930003231 vitamins Natural products 0.000 description 1
• 238000002424 x-ray crystallography Methods 0.000 description 1
• 239000008096 xylene Substances 0.000 description 1
• 239000007222 ypd medium Substances 0.000 description 1
• 229910052727 yttrium Inorganic materials 0.000 description 1
• UHBYWPGGCSDKFX-VKHMYHEASA-N γ-carboxy-L-glutamic acid zwitterion Chemical compound OC(=O)[C@@H](N)CC(C(O)=O)C(O)=O UHBYWPGGCSDKFX-VKHMYHEASA-N 0.000 description 1